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Background and purpose. Intracranial 
aneurysms in childhood are rare and population-
based long-term follow-up studies are limited. In 
this study, a large clinical and angiographic long-
term follow-up was carried out. The special char-
acteristics of the patients and their aneurysms 
were assessed together with factors affecting 
early and long-term morbidity and mortality.
Materials and methods. All pediatric (≤18 
years) aneurysm patients treated at the Depart-
ment of Neurosurgery in Helsinki during 1937-
2009 were followed from diagnosis until death or 
the end of the year 2011. For every patient, hos-
pital records and radiological examinations were 
analyzed retrospectively. Later patient data were 
gathered from the referring hospitals. A new fol-
low-up was organized as a written questionnaire 
to assess the latest clinical outcome. The long-
term excess mortality was calculated by using 
relative survival ratio in these patients compared 
with the mortality of the general Finnish popula-
tion matched by age, gender, and calendar time.
Results. Patients comprised 114 individuals 
with 130 aneurysms. The mean age of patients 
was 14.5 years (range 3 mths -18 yrs). The boy/girl 
ratio was 3:2. Altogether 89 patients (78%) pre-
sented with subarachnoid hemorrhage (SAH). The 
majority (n=116, 89%) of the aneurysms were in 
the anterior circulation, the most common loca-
tion being internal carotid artery (ICA) bifurcation 
(n=36, 28%). The average aneurysm diameter was 
11 mm (range 2-55 mm) with 16 giant aneurysms 
(12%). Of the aneurysms, 84 (65%) were treated 
surgically and 32 (25%) conservatively due to poor 
condition of the patient or for technical reasons 
during the early years of the series. After a mean 
follow-up time of 24.8 years (range 0-55.8 yrs), 71 
patients (62%) had a good outcome, three (3%) 
were dependent, and 40 (35%) had died. Of the 
deaths, 68% were assessed to be aneurysm-re-
lated. Of the survivors, 91% lived independently at 
home and were meaningfully employed. Twenty-
eight percent of the survivors were high school 
graduates. Factors correlating with a favorable 
long-term outcome were aneurysm location in 
the internal carotid artery or anterior communi-
cating artery, operative treatment, and complete 
aneurysm closure postoperatively. Fourteen pa-
tients (12%) had a family history of aneurysms.
Fifty-nine patients had long-term angiographic 
follow-up data (median follow-up 34 yrs; range 
4-56 yrs). Of these patients, 24 (41%) were diag-
nosed with a total of 36 new aneurysms. There 
were 25 de novo-aneurysms and 11 recurrent 
aneurysms, and seven SAHs. The annual rate of 
development of de novo- or recurrent-aneurysm 
was 1.9% and that of hemorrhage 0.4%. There 
were no de novo aneurysms in patients with pri-
marily unruptured aneurysms. Current or previous 
smoking (odds ratio [OR] 3.39, 95% confidence 
interval [CI] 1.02-11.29, p=0.047) was the only 
significant risk factor for de novo and recurrent 
aneurysm formation. Surprisingly, hypertension, 
gender, age at onset, initial number of aneu-
rysms, initial rupture status, or family history had 
no statistically significant effect. No statistically 
significant independent risk factors for new SAH 
emerged. Cumulative risk of new SAH 40 years af-
ter the initial diagnosis was 15% (95% CI 5-25%).
There was an overall excess mortality of 10% (cu-
mulative RSR 0.90, 95% CI 0.80-0.95) and 19% 
(cumulative RSR 0.81, 95% CI 0.67-0.92) at 20 and 
40 years after the diagnosis among one-year sur-
vivors, respectively. The excess mortality was par-
ticularly high in male patients. Aneurysm-related 
deaths included rebleedings from open or partially 
occluded aneurysms, epileptic seizures, de novo 
and recurrent aneurysms, or sequelae of SAH.
Conclusions. Most aneurysms were ruptured 
and of medium size. ICA bifurcation was the most 
common location, and males were predominantly 
affected. Most patients had a good recovery, but 
almost half of them developed de novo and recur-
rent aneurysms during a follow-up of 34 years, with 
smoking being a major risk factor. A long-term ex-
cess mortality exists in pediatric aneurysm patients, 
especially males, even decades after successful 
treatment of a ruptured aneurysm. The excess mor-
tality is mainly aneurysm-related. A life-long angio-
graphic follow-up is mandatory in these patients.
Abstract
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A
bstract
Tausta ja tarkoitus. Aivovaltimoaneurysmat 
ovat harvinaisia lapsilla, ja tämän potilasryhmän 
väestöpohjaiset pitkäaikaiset seurantatutkimukset 
ovat rajallisia. Tässä tutkimuksessa suoritettiin kliininen 
ja radiologinen pitkäaikaisseuranta lapsuudessa 
aivovaltimoaneurysmadiagnoosin saaneille potilaille. 
Potilaiden ja aneurysmien erityispiirteet määritettiin, 
sekä selvitettiin tämän potilasryhmän pitkän aikavälin 
sairastuvuus sekä ylikuolleisuus. Potilaiden riski 
saada uusia aneurysmia sekä uusi aneurysmavuoto 
selvitettiin, sekä arvioitiin näihin vaikuttavat 
riskitekijät.
Materiaalit ja menetelmät. Kaikkien Helsingissä 
Neurokirurgian klinikassa vuosien 1937-2009 aikana 
hoidettujen aneurysmadiagnoosin saaneiden 
lapsipotilaiden (≤ 18 vuotta) sairaskertomushistoria 
selvitettiin. Potilaan kliiniset tiedot röntgenkuvineen 
analysoitiin, ja myöhempi sairaushistoria selvitettiin 
muista sairaaloista. Uusi seuranta järjestettiin 
kirjallisena kyselytutkimuksena. Pitkän aikavälin 
kuolleisuus laskettiin käyttäen suhteellista eloonjääntiä 
verrattuna ikä-, sukupuoli- ja kalenteri-ikä-vakioituun 
Suomen väestöön.
Tulokset. Seuranta-aikana hoidettiin 114 
lapsianeurysmapotilasta, joilla oli yhteensä 130 
aneurysmaa. Potilaiden keski-ikä oli 14,5 vuotta 
(vaihteluväli 3 kk -18 v). Poika/tyttö-suhde oli 3:2. 89 
(78%) potilaalla oli lukinkalvonalainen verenvuoto 
(SAV). Suurin osa, 28%, aneurysmista sijaitsi sisemmän 
kaulavaltimon huipussa. Keskimääräinen aneurysman 
halkaisija oli 11 mm (vaihteluväli 2-55 mm) ja 
aneurysmista 16 (12%) oli kooltaan jättianeurysmia. 
Potilaista 65%:lla aneurysma hoidettiin kirurgisesti. 
Syynä konservatiiviseen hoitoon oli potilaan huono 
kliininen vointi tai aneurysman soveltumattomuus 
kirurgiseen hoitoon potilassarjan alkuvuosina. 24,8 
vuoden (vaihteluväli 0-55,8 v) seurannassa potilaista 
71 (62%) oli toipunut hyvin, kolme (3%) oli muiden 
hoidosta riippuvaisia ja 40 (35%) oli kuollut. 68% 
kuolemista arvioitiin olevan aneurysmaan liittyviä. 
Eloonjääneistä 91% asui itsenäisesti kotona ja oli 
työelämässä tai opiskeli. 28% eloonjääneistä oli 
suorittanut vähintään lukion oppimäärän. Suotuisaan 
pitkän aikavälin ennusteeseen vaikuttivat aneurysman 
sijainti sisemmän kaulavaltimon tai etummaisen 
yhdysvaltimon alueella, operatiivinen hoito ja 
täydellinen aneurysman sulku. Neljäntoista (12%) 
potilaan suvussa oli taipumus aivovaltimoaneurysmiin.
Potilaista 59:llä oli radiologisia seurantatietoja 
aneurysmasta (mediaani seurantaaika 34 v, vaihteluväli 
4-56 v). Näistä 24 (41%) potilaalla diagnosoitiin 
yhteensä 36 uutta aneurysmaa,  joista 25 oli de 
novo-aneurysmia ja 11 uusiutuneita aneurysmia. 
Seitsemän uutta SAV:tä diagnosoitiin. Vuotuinen 
riski de novo- tai uusiutuneelle aneurysmalle oli 
1,9%, ja SAV:lle 0,4%.  Nykyinen ja aiempi tupakointi 
(riskisuhde [OR], 3.39, 95% luottamusväli [CI] 1.02-
11.29, p = 0,047) oli ainoa tilastollisesti merkittävä 
riskitekijä de novo- ja uusiutuneiden aneurysmien 
muodostumiselle. Verenpainetaudilla, sukupuolella, 
iällä diagnoosihetkellä, alkuperäisen aneurysman 
vuotostatuksella tai suvun aneurysmataipumuksella 
ei ollut tilastollisesti merkitsevää vaikutusta uusien 
aneurysmien syntyyn. Uudelle SAV:lle ei löytynyt 
tilastollisesti merkitseviä itsenäistä riskitekijöitä. 
Uuden SAV:n kumulatiivinen riski 40 vuotta 
ensimmäisen vuodon jälkeen oli 15% (95% CI 5-
25%). Potilailla, jotka olivat elossa vuoden kuluttua 
aneurysmadiagnoosista, oli 20 vuoden kohdalla 
10%:n (kumulatiivinen RSR 0,90, 95% CI 0,80-0,95) 
ja 40 vuoden kohdalla 19%:n (kumulatiivinen RSR 
0,81, 95% CI 0,67-0,92) ylikuolleisuus. Aneurysmaan 
liittyvät kuolemat johtuivat mm. uusintavuodosta, 
joka aiheutui avoimesta tai osittain suljetusta 
aneurysmasta, epileptisistä kohtauksista, sekä de 
novo- ja uusiutuneiden aneurysmien aiheuttamista 
uusista SAV:sta.
Johtopäätökset. Useimmat aneurysmista olivat 
vuotaneita ja keskikokoisia. Sisemmän kaulavaltimon 
huippu oli aneurysmien yleisin sijaintipaikka. Valtaosa 
potilaista oli poikia. Useimmat potilaat toipuivat 
hyvin, mutta lähes puolella heistä todettiin uusi 
aneurysma yli 34 vuoden pitkäaikaisseurannassa. 
Tupakointi oli ainoa merkittävä riskitekijä 
uuden aneurysman synnylle. Lapsuudessa 
aivovaltimoaneurysmadiagnoosin saaneilla potilailla 
todettiin pitkäaikaisseurannassa ylikuolleisuutta 
vuosikymmeniä onnistuneenkin aneurysman hoidon 
jälkeen, etenkin miespotilailla. Tämä ylikuolleisuus 
johtuu lähinnä aneurysmariippuvista tekijöistä. 




Bakgrund och syfte. Med ett aneurysm avses 
en tunväggig, påsartad dilatation av en artär. Ruptur 
av ett aneurysm i en hjärnartär leder till en subarach-
noidalblödning (SAH). Intrakraniella aneurysm hos 
barn är ovanliga och det har publicerats endast ett fåtal 
populationsbaserade studier om långtidsprognosen. 
I detta arbete presenteras en stor klinisk och angio-
grafisk långtidsuppföljning av aneurysm hos barnpati-
enter. Patienternas och aneurysmens kliniska särdrag 
evaluerades jämte faktorer som känt påverkar långtid-
sprognosen och dödligheten hos aneurysmpatienter.
Material och metoder. Alla pediatriska (≤ 18 år) 
aneurysmpatienter vid Neurokirurgiska kliniken i Hel-
singfors under 1937-2009 uppföljdes från diagnos till 
döden eller slutet av år 2010. Varje patients sjukhus-
journaler och radiologiska undersökningar analyse-
rades retrospektivt. Senare patientdata insamlades 
från andra sjukhus. De färskaste uppgifterna insam-
lades medelst en skriftlig enkät i syfte att utvärdera 
patienternas kliniska tillstånd. Långtidsöverlevnaden 
beräknades med hjälp av ett statistiskt program som 
jämför den relativa överlevnaden hos dessa pati-
enter med genomsnittsöverlevnaden hos Finlands 
befolkning anpassat efter ålder, kön och kalendertid.
Resultat. Studien omfattar 114 patienter med 130 
aneurysm. Medelåldern hos patienterna var 14,5 år 
(intervall 3 mån -18 år). Pojke/flicka förhållandet var 3:2. 
89 (78%) av patienterna uppvisade en SAH. Majoriteten 
(n = 116, 89%) av aneurysmen var lokaliserade till den 
främre cirkulationen, och den vanligaste platsen var 
inre karotidartärens (ICA) bifurkation (n = 36, 28%). Den 
genomsnittliga aneurysm- diametern var 11 mm (in-
tervall 2-55 mm) med 16 (12%) jätteaneurysm (största 
diametern över 25mm). 84 (65%) av aneurysmen be-
handlades kirurgiskt och 32 (25%) behandlades kon-
servativt på grund av av patientens medtagna tillstånd 
eller av tekniska skäl under de första åren i serien. Efter 
en genomsnittlig uppföljningstid på 24,8 år (intervall 
0-55,8 år) hade 71 (62%) patienterna ett bra resultat, 
tre (3%)  behövde kontinuerlig vård och 40 (35%) hade 
avlidit. 68% av dödsfallen bedömdes vara aneurysm-
relaterade. Av de överlevande bodde 91% självstän-
digt hemma och hade ett självständigt arbete. 28% av 
de överlevande hade avlagt studentexamen. Faktorer 
som korrelerar med en gynnsam prognos var aneurys-
mets lokalisation i ICA eller främre förbindelseartären 
(ACoA), operativ behandling och fullständig tillslutning 
av aneurysmet postoperativt. Fjorton (12%) patienter 
hade en positiv familjehistoria för hjärnartäraneurysm.
Femtionio patienter hade angiografiska långtidsup-
pföljningsdata (medianen för uppföljningstiden 34 år, 
intervallen 4-56 år). Av dessa diagnostiserades 24 (41%) 
med totalt 36 nya aneurysm. Det fanns 25 nya (de 
novo) aneurysm och 11 recidivaneurysm och sju pati-
enter drabbades av en SAH under uppföljningstiden. 
Risken för utveckling av ett de novo eller recidivaneu-
rysm var 1,9%/ år och för blödning 0,4%/år. Det fanns 
inga de novo aneurysm hos patienter med primärt inte 
rupturerat aneurysm. Fortgående och även tidigare 
avslutad rökning var den enda betydande riskfaktorn 
för bildning av de novo och recidivaneurysm(oddskvot 
[OR], 3,39, 95% CI, 1,02 till 11,29, p = 0,047). Förhöjt 
blodtryck, kön, ålder vid insjuknandet, ruptur/icke 
ruptur av aneurymet primärt eller positiv släkthistoria 
hade ingen statistiskt signifikant betydelse. Det fanns 
inga statistiskt signifikanta oberoende riskfaktorer för 
en ny SAH. Den kumulativa risken för en ny SAH 40 år 
efter den första diagnosen var 15% (95% CI, 5-25%). 
Studien visade en överdödlighet på 10% (kumulativ 
RSR 0,90, 95% konfidensintervall (CI) 0,80 till 0,95) och 
19% (kumulativ RSR 0,81, 95% CI 0,67 till 0,92) vid 20 
respektive 40 år hos de patienter som överlevt åtmin-
stone ett år efter det att diagnosen ställts. Överdöd-
ligheten var betydligt högre hos män. De aneurysm-
relaterade dödsfallen innefattade återblödning från 
öppna eller delvis tillslutna aneurysm, epileptiska anfall, 
de novo och recidivaneurysm eller  följder av en  SAH.
Slutsatser. De flesta aneurysmen hade rupture-
rat och var medelstora. ICA bifurkationen var den 
vanligaste lokalisationen. Aneurysm förekom mera 
allmänt hos män. De flesta patienterna återhämtade 
sig väl, men nästan hälften av dem utvecklade de 
novo eller recidivaneurysm under en genomsnittlig 
uppföljning på 34 år med rökning som en viktig riskfak-
tor. Barnpatienter med hjärnartäraneurysm uppvisar 
en överdödlighet även decennier efter framgångsrik 
behandling av ett rupturerat aneurysm, speciellt hos 
män. Överdödligheten är huvudsakligen relaterad 
till aneurysmet. En livslång uppföljning med uppre-
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AC  Aortic coarctation
ACA  Anterior cerebral artery
ACoA  Anterior communicating artery
ADPKD  Autosomal dominant polycystic kidney disease
AVM  Arteriovenous malformation
BA  Basilar artery
CCA  Common carotid artery
CFD  Computational fluid dynamics
CI  Confidence interval
CSF  Cerebrospinal fluid
CT  Computed tomography
CTA  Computed tomography angiography
DCI  Delayed cerebral infarct
DIND  Delayed ischemic neurologic deficit
DSA  Digital subtraction angiography
ELANA  Excimer laser-assisted nonocclusive anastomosis
ETV  Endoscopic third ventriculostomy
EVD  External ventricular drainage
FMD  Fibromuscular dysplasia
GDC  Guglielmi detachable coil
GOS  Glasgow outcome scale
HIV  Human immunodeficiency virus
HUCH  Helsinki University Central Hospital
ICA  Internal carotid artery
ICH  Intracerebral hemorrhage
ICP  Intracranial pressure
ISPN  International Society of Paediatric Neurosurgery
IVH  Intraventricular hemorrhage
MCA  Middle cerebral artery
MRA  Magnetic resonance angiography
MRI  Magnetic resonance imaging
mRS  Modified Rankin scale
NF-1  Neurofibromatosis type 1
OI  Osteogenesis imperfecta
OR  Odds ratio
PCA  Posterior cerebral artery
PCoA  Posterior communicating artery
PICA  Posterior inferior cerebellar artery
PXE  Pseudoxanthoma elasticum
RSR  Relative survival ratio
SAH  Subarachnoid hemorrhage
SCA  Superior cerebellar artery
TCD  Transcranial Doppler
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Intracranial arterial aneurysms are a fairly 
common cerebrovascular disease, affect-
ing about 1-5% of the general population.241 
Rupture of an aneurysm is a sudden and 
devastating incident that results in subarach-
noid hemorrhage (SAH). Initial bleeding from 
a ruptured aneurysm is fatal in 12-15% of 
cases, with death often occuring before pa-
tients even reach the hospital.90,93,211,222,262 
Rebleeding of an aneurysm is a feared event, 
and its consequences have a significant im-
pact on mortality and morbidity.190 Ruptured 
aneurysms are therefore nowadays usually 
treated within 24-48 hours of the rupture. 
Treatment methods include microsurgical 
clipping of the aneurysm neck by a neurosur-
geon or endovascular techniques where the 
aneurysm is occluded through intra-arterial 
techniques performed by a neuroradiologist. 
Aneurysmal SAH affects about 100 000 peo-
ple yearly in Western countries,8,37,49,130,206, 
being most prevalent in the working popula-
tion, in people in their 40’s and 50’s.183,312 In 
children and adolescents, by contrast, intra-
cranial aneurysms are rare, constituting only 
about 0.5-2% of all aneurysms. 3,81,87,117,207,216,249
In adult patients, acquired risk factors for aneu-
rysm growth and rupture are smoking, hyper-
tension, and excessive alcohol consumption,50 
factors practically nonexistent in children. 
Connective tissue disorders causing fragile 
vessel walls, and congenital heart diseases 
causing elevated blood pressure are known 
risk factors for intracranial aneurysm forma-
tion in children.207,216,254,264 Pediatric aneurysm 
patients differ from adults also regarding their 
clinical presentation, aneurysm morphology, 
and outcome.135,270 There is a male predomi-
nance159,207 and aneurysms tend to be larger 
in children.3 Moreover, the location of aneu-
rysms differs between children and adults.225
The overall one-year case fatality after SAH 
in adult patients is about 50%.58,75 During the 
last decades the case-fatality rate has not im-
proved markedly.90 Patients who survive SAH 
have a higher occurrence of a new SAH than in 
the general population, even after successful 
treatment of the initial aneurysm, due to de 
novo- and recurrent-aneurysms.20,321 Among 
adult SAH patients, long-term excess mortality 
has been described101,242 to be mainly due to 
the high incidence of cardiovascular deaths. 
Population-based long-term follow-up stud-
ies among pediatric patients are scarce. 
Over the years, some case reports,43,65,67-
69,71,105,157,182,188,200,223,231,271,272,289,291,325,336,337 and 
smaller patient series together with litera-
ture reviews 2,3,22,80-82,87,92,110,117,135,159,171,180,193,2
07,215,216,225,249,250,265,270,282,307,333 have been pub-
lished. In pediatric patients, long-term angio-
graphic follow-up studies are quite rare; avail-
able studies have mean follow-up times of 
4-6 years.86,117,250 No long-term excess mortality 
studies have been published among children 
and adolescents with intracranial aneurysms.
In this study, data on long-term clinical and 
angiographic follow-up studies of pediatric in-
tracranial aneurysm patients admitted to the 
Department of Neurosurgery, Helsinki Univer-
sity Central Hospital (HUCH), during 1937-2009 
were gathered. Special characteristics of these 
patients and factors affecting long-term out-
come were assessed. Patient survival was set to 
define long-term excess mortality. The annual 
rate of these patients to develop de novo- and re-
current aneurysms, and new SAH together with 
the risk factors for these events were assessed.
Finland is ideal for long-term follow-up studies 
due to our high-quality public health care system 
with population responsibility and accessible 
hospital records and patient registries together 
with a stable and geographically relatively isolat-
ed population of 5.4 million. Typically, patients 
can be located even after decades and most 
are willing to participate in follow-up studies.
1. Introduction
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2. Review of the literature
2.1 Intracranial aneurysms and 
subarachnoid hemorrhage in 
the adult population
The prevalence of cerebral aneurysms in the 
adult population is estimated to be 1-5%.233,241 
Thus, over 100 000 adults in Finland are po-
tentially carrying unruptured aneurysms. An-
eurysms are typically located at the branching 
points of arteries in the Circle of Willis (Figure 
1). Saccular intracranial aneurysm disease is 
complex, like hypertension or diabetes type 2, 
with a familial predisposition.100 Its genomics 
is currently being studied.62,331,332 Risk factors 
for aneurysm formation are female gender,233 
hypertension, hypercholesterolemia, smok-
ing, and heart disease.103 In Finland, as in Ja-
pan, the incidence of SAH is threefold that 
of other industrialized countries,57,211,252 and 
about 1000 new SAHs are diagnosed yearly. 
In about 30% of patients, multiple aneurysms 
occur.234,236  Risk factors for aneurysm rupture 
are female gender, older age, smoking, exten-
FIGURE 1.
Base of the brain and Circle of Willis (A). Typical locations of aneurysms with proportions in adult 
SAH patients (B).35,84,100,166,168,234,235,319 ACA = anterior cerebral artery, ACoA= anterior communicating 
artery, MCA=middle cerebral artery, ICA bif =internal carotid artery bifurcation, PCoA =posterior 





sive alcohol consumption, family 
history, and large size and location 
of aneurysms.14,37,88,106,114,116,324,327 A 
recent study showed that the locations of rup-
tured and unruptured aneurysms varied, sug-
gesting different etiological reasons for the for-
mation and rupture of cerebral aneurysms.100 
Furthermore, the role of family history and 
genetics in aneurysmal SAH has recently been 
under discussion.133 The differential impact of 
known risk factors on formation of intracranial 
aneurysms or rupture of the aneurysm wall is 
not clear. Minor proportions of aneurysms are 
due to direct vascular trauma (i.e. traumatic 
aneurysms)10,137 or bacterial infection (i.e. my-
cotic aneurysms).31,59,137 The overall case fatality 
during the first year is about 50%; this figure 
has remained the same over the last few de-
cades.90,222,273,280 Vasospasm and rebleedings 
have a major effect on outcome,124 together 
with the neurological condition of the patient 
on admission, age, Fisher grade54 (see Appen-
dix I), aneurysm location,243 and co-morbidi-
ties.124 Overall, 60-80% of  adult SAH patients 
have a favorable outcome (Glasgow outcome 
scale (GOS)≥4).85,132,253 Previous SAH patients 
have a higher occurrence of a new SAH than 
in the general population, even after success-
ful treatment of the initial aneurysm, due to de 
novo and recurrent aneurysms.20,302,321 




2.2.1.1. Development of intracranial arteries
Development of cerebral vasculature is staged 
according to Padgett’s seven stages.251 The ar-
terial system in the fetal brain is determined 
early,229 essentially achieving an adult pattern 
by the end of the embryonic period (embryonal 
week eight), whereas the venous system devel-
ops later in the fetal period.251,301
2.2.1.2. Normal arterial wall versus 
aneurysm wall
The wall of a normal healthy artery is divided 
into three distinctive layers, i.e. the tunica in-
tima, tunica media, and tunica adventitia. In-
tracranial medium-sized arteries have smooth 
muscle cells in both intimal and medial layers 
and a prominent elastic membrane in the inti-
mal layer. The main components in the connec-
tive tissue of the artery wall are collagen, elastin, 
and proteoglycans.184 Collagen is the major con-
nective tissue in the medial layer. In the arterial 
bifurcations, a common location for aneurysms, 
the collagen is organized in such a way that fur-
ther stabilizes the bifurcation region.52 The con-
nective tissue maintains the configuration of 
the artery and is responsible for the stretching 
properties and tensile strength of the artery. The 
majority, 80-90%, of the collagens in arteries are 
of types I and III.184 Type IV collagen exists in the 
basement membrane.191
 
The exact mechanisms by which aneurysms 
form are unknown. The wall of a cerebral artery 
is thinner than that of other equally sized arter-
ies.184 The intracranial arteries lack the outer 
elastic membrane between the tunica media 
and tunica adventitia. Furthermore, in the sub-
arachnoid space, the cerebral arteries do not 
have physical support from surrounding tissues, 
contrary to the arteries in other parts of the 
body.266
2.2. Pediatric hemorrhagic 
stroke
Pediatric stroke is a rather frequent cause of death 
in childhood, with an incidence of 2–13 /100 000 
children.30 About half of the strokes in the young 
are hemorrhagic,109 including both intracerebral 
hemorrhages (ICH) and non-traumatic SAH. The 
other half, arterial ischemic stroke and cerebral 
venous thrombosis, are referred to as ischemic 
stroke, both resulting in venous infarction. The 
most frequent cause of hemorrhagic stroke in 
children is rupture of an arteriovenous malforma-
tion (AVM), constituting 30% of all hemorrhagic 
strokes.30 Cerebral aneurysms account for about 
13% of hemorrhagic strokes.110 Cavernous malfor-
mations,110,275 Moyamoya disease,102,276 and sickle 
cell disease286 may also present with hemorrhagic 
stroke in the pediatric population.30
Intracranial aneurysms in children constitute 
about 0.5-4% of all aneurysms.3,159 Only a few in-
stitutional series (Table 1) and  case reports (Table 
2),  have been published on these rare patients.
2.2.1. Pathobiology of aneurysms
In the adult population, intracranial aneurysms 
are regarded as acquired rather than congenital 
vascular lesions. However, risk factors for aneu-
rysm formation that are common in the adult 
aneurysm population are virtually absent in the 
pediatric population, indicating distinct modes 
of pathogenesis of cerebral aneurysms in these 
populations.1 Co-morbidities predisposing chil-
dren to intracranial aneurysms include systemic 
connective tissue disorders and congenital heart 
diseases that elevate blood pressure. A classifica-
tion according to the pathogenetic mechanism 
of pediatric intracranial arterial aneurysms has 
been proposed with eight distinct categories: id-
iopathic, traumatic, those due to excessive hemo-
dynamic stress, vasculopathic, infectious, nonin-
fectious inflammatory, oncotic, and familial.1 









Patel et al. 216 1971 58 ≤20 100
Sedzimir et al. 265 1973 50 ≤20 100
Heiskanen et al. † 81 1981 32 ≤19 100
Ostergaard et al. 207 1983 43 ≤19 77
Pasqualin et al. 215 1986 31 ≤20 96
Heiskanen et al. † 80 1989 16 <20 100
Meyer et al. 193 1989 23 ≤18 57
Herman et al. 82 1991 16 ≤18 44
Drake et al.40 ‡ 1996 49 ≤18 49
Allison et al.3 1998 21 ≤15 71
Proust et al. 225 2001 22 ≤16 95
Lasjaunias et al. 159 2005 59 ≤15 51
Agid et al. 2 2005 33 ≤17 36
Present series 114 ≤18 78
TABLE 1.
Pediatric aneurysm patients series with year published, number of patients (No.), patient’s age and 
proportion of patients presenting with subarachnoid hemorrhage (SAH).
† patient material partly overlapping






Krishna et al.135 2005 22 ≤18 91
Huang et al. 92 2005 19 ≤18 58
Sanai et al. 250 2006 32 ≤18 22
Sharma et al. 270 2007 55 ≤18 78
Stiefel at al. 282 2008 12 ≤16 100
Vaid et al. 307 2008 27 ≤18 100
Liang et al. 171 2009 24 ≤14 46
Hetts et al. 87 2009 77 ≤18 32
Jordan et al. 110 2009 15 ≤19 100
Songsaeng et al. 278 2009 8 <16 25
Lv et al. 180 2009 25 ≤17 11
Sanai et al. 249 2010 32 ≤18 44
Kakarla et al. 117 2010 48 ≤18 17
Present series 114 ≤18 78
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Age has an impact on the thickness of the in-
timal layer; children have a thin layer, while in 
older vessels the intimal layer has thickened 
due to lipid deposits. Hypertension affects 
the medial layer by increasing the amount 
of smooth muscle cells, whereas athero-
sclerosis affects the intimal layer with lipid 
accumulation and fibrofatty lesions. In the 
aneurysm wall, fibrosis of the medial layer is 
found at the expense of loss of muscle mass, 
i.e. there are gaps in the media layer where 
normal muscle tissue is replaced by connec-
tive tissue.52 In studies of pediatric human 
immunodeficiency virus (HIV)-related intrace-
rebral aneurysms, destruction of the internal 
elastic lamina and hyperplasia of the intimal 
layer were also found.41,140 Studies focusing 
on the histology of ruptured aneurysm walls 
have revealed the underlying role of inflam-
mation processes.60,304,305 The complement 
system becomes activated by the classical 
pathway in intracranial aneurysm walls.303
2.2.1.3. Flow dynamics
Blood flow dynamics inside cerebral aneurysms 
and in their vicinity has been implicated in an-
eurysm study. Computational fluid dynamics 
(CFD) simulations of intracranial aneurysm he-
modynamics have in recent years been used to 
evaluate the risk of growth and rupture of un-
ruptured aneurysms.53 Wall shear stress (WSS) 
expresses the force per unit area exerted by 
the wall on the fluid along the local tangent 
plane.126 Vessel wall remodeling as a result of 
WSS alteration is accompanied by synthesis 
and secretion of nitrogen oxide, growth fac-
tors, and metalloproteins.212 The temporospa-
tial variations of aneurysm wall pressure and 
WSS in the aneurysm are assumed to correlate 
with continuous expansion and eventual rup-
ture.309 These simulations usually adopt simpli-
fications of Newtonian and non-Newtonian53 
blood rheology models. Models are used to 
produce intra-aneurysmal flow patterns and 
surface distributions of shear rate, blood vis-
cosity, and WSS. CFD has also been implicated 
Author Year
Vapalahti et al. 313 1969
Manz et al. 188 1979
Iob et al. 105 1983
Lansen et al. 157 1989
Nishio et al. 200 1991
Willemsen et al. 325 1997
Gewirtz65 1998
Young et al. 336 2000
Grosso71 2002
Zhang et al. 337 2002
Sungarian et al. 289 2003
Gralla69 2004
Gonzales-Portillo68 2006
Prochazka et al. 223 2007
Tanaka et al. 291 2007
Eddleman43 2007
Mahadevan et al. 182 2008
Reig et al.231 2009
Goedee67 2009
Shih et al. 272 2010
Shelton et al. 271 2011
Sabanci et al. 247 2012
TABLE 2.
Case reports of pediatric aneurysm patients 
with years published.




in the hemodynamic effects of aneurysm coil 
embolization.263 A recent study suggested that 
the combination of high WSS and high posi-
tive spatial WSS gradient focused on a small 
segment of the arterial wall may have a role 
in the initiation of aneurysm formation.136
2.2.2. Special characteristics of 
pediatric patients 
Altogether 26 patient series on pediatric cere-
bral aneurysms together with 22 case reports 
were found in the literature (Tables 1 and 2). 
The total number of patients in the literature 
review was 871, with 949 aneurysms. The 
majority (56%) of the patients were males. 
2.2.2.1. Gender and age
There is a male predominance throughout the 
literature in pediatric aneurysm patients.159,207 
In a series with 59 patients, the overall male 
to female ratio was 3:2; however, among chil-
dren under two years of age, the incidence of 
aneurysms was higher in girls (girl:boy ratio 
5:1).159 Aneurysms in infants are extremely 
rare.313 In patients harboring aneurysms dur-
ing the first year of life, 21% were reported to 
have co-morbidities such as cutaneous vascu-
lar disorder, autosomal dominant polycystic 
kidney disease (ADPKD), or brain tumors.22
2.2.2.2. Predisposing factors
Disorders generally known to predispose chil-
dren to intracranial aneurysms include ADPKD, 
tuberous sclerosis complex, Marfan syndrome, 
osteogenesis imperfecta, Ehlers-Danlos syn-
drome, and fibromuscular dysplasia. Aortic 
coarctation causing elevated blood pressure 
in the vascular system above the coarctation 
causes extensive hemodynamic stress to in-
tracranial arteries. The incidence, patterns 
of inheritance, and systemic manifestations 
of these disorders are presented in Table 3. 
Autosomal dominant polycystic kidney 
disease
ADPKD is the most common inherited kidney 
disorder.296 Patients with ADPKD have an in-
creased frequency of intracranial aneurysms, 
with estimates of prevalence ranging from 4% 
to 41%, and the morbidity of aneurysmal SAH 
is higher in patients with ADPKD.17,25 In a recent 
study,328 over 350 patients with ADPKD aged 7-
78 years were screened for intracranial aneu-
rysms, and 12% were found to harbor them, 
this figure being more common than in pre-
vious studies.98,245 There was only one patient 
with aneurysms under the age of 29 years; 
however, information about the exact age is 
not provided.328 The prevalence of intracranial 
aneurysms increases with age, reaching a peak 
value of 23% in patients over 60 years of age, 
and being higher in patients with a positive 
family history for aneurysms.328 Thus, the study 
recommends systematic screening of intracra-
nial aneurysms for patients with ADPKD, par-
ticularly adult patients (>30 years) or patients 
with a positive family history for aneurysms.328 
A Finnish study showed that members of AD-
PKD families share a high risk of having intra-
cranial aneurysms, but the risk is comparable 
with that of familial intracranial aneurysm 
families.240 For pediatric patients, it has been 
proposed that ADPKD in a child with a positive 
family history for intracranial aneurysms war-
rants screening for intracranial aneurysms.238
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TABLE 3.
Connective tissue disorders predisposing to intracranial arterial aneurysm formation in childhood. 
AD=autosomal dominant, ADPKD =autosomal dominant polycystic kidney disease, AR=autosomal recessive.
Incidence Inheritance Manifestations
ADPKD33
1-2/1000 AD Hypertension, 
hepatic cysts
Marfan Sdr226
1/5000 AD Aortic stenosis,
myopia
Osteogenesis imperfecta310 6–7/100 000•281 AD† Bone fractures,
hearing loss
Tuberosis sclerosis248 1/6000 AD Hamartomas, 
giant cell astrocytoma
Pseudoxanthoma elasticum306 1/25000•26 AR‡ Ocular, dermal and 
cardiovascular 
Ehlers-Danlos Sdr type IV12 0.4-1/100000 AD Arterial, intestinal and 
uterine ruptures
Neurofibromatosis type I185 1/3000202 AD Neurofibromas, 
optic glioma
Fibromuscular dysplasia297 2/100 AD Hypertension, 
ischemic renal atrophy
• birth prevalence
† 10% recessive variants in eight other genes310
‡ rarely AD220
Tuberous sclerosis complex
Tuberous sclerosis complex is a neurocutane-
ous syndrome with a variable clinical expres-
sion. It is a multisystem disorder that may be 
associated with hamartomas in multiple or-
gans in an unpredictable manner. However, 
vascular involvement in tuberous sclerosis is 
rare.248 Central and peripheral aneurysms and 
large- and medium-sized arterial stenotic-oc-
clusive disease have been reported.271,248,298 In 
a review article, 15 cases of tuberous sclero-
sis patients diagnosed with intracranial aneu-
rysm were identified.9 However, no screening 
for aneurysms in asymptomatic patients is 
recommended.9 Intracranial aneurysms asso-
ciated with tuberous sclerosis are mainly fusi-
form in shape.
Marfan sydrome
Marfan syndrome usually manifests with  ab-
normalities in bones, eyes, heart, and vascular 
system.226 Marfan syndrome results in abnor-
mal elastic tissue, with a defect in the fibrillin 
gene. Recent studies have also revealed the 
role of dysregulation of cytokine-transforming 
growth factor beta signaling in Marfan syn-
drome.13 Neurovascular symptoms associated 
with this syndrome include arterial dissections 
and (saccular) intracranial aneurysms.257 In an 
autopsy study260 with adult Marfan syndrome 
patients, 29% were diagnosed as having intra-
cranial aneurysms. On microscopic examina-
tion, the cerebral arteries had intimal prolifera-
tion, medial degeneration, and fragmentation 
of the internal elastic lamina.260





Osteogenesis imperfecta (OI) is a heterogeneous 
group of heritable disorders characterized by in-
creased bone fragility.310 The neurologic compli-
cations mostly concern skeletal disorders such as 
basilar invagination. OI is associated with type I 
collagen abnormalities, which may cause vascu-
lar complications. However, the cerebrovascular 
system is not usually involved in OI.218 Some cases 
of carotid-cavernous fistulae and vertebral artery 
dissections in OI patients have been reported.257 
Aneurysmal SAH is extremely rare.189
Ehlers-Danlos syndrome type IV
Ehlers-Danlos syndrome is a diverse group of 
connective tissue disorders.184 Typical findings in-
clude abnormal skin elasticity, impaired healing 
of wounds, joint hypermobility, and overall tissue 
fragility. Patients diagnosed with Ehlers-Danlos 
syndrome type IV, also called vascular Ehlers-
Danlos syndrome, notoriously have fragile blood 
vessels due to abnormal procollagen III synthe-
sis,12 and the reported mortality rate for any 
type of vascular surgical procedure is high.63,204,256 
Typical neurovascular complications of Ehlers-
Danlos syndrome are carotid-cavernous fistulae, 
intracranial aneurysms, and cervical artery dis-
sections.257 The youngest child described with 
Ehlers-Danlos syndrome type IV and intracranial 
aneurysms is a 5-year-old girl.125 
Pseudoxanthoma elasticum
Pseudoxanthoma elasticum (PXE) mainly pres-
ents with anomalies of the skin, eye, heart, and 
vascular system.306 It is characterized by ectopic 
mineralization and fragmentation of elastic fi-
bers of connective tissues.306  Premature arte-
riosclerosis in small- and medium-sized arteries 
leads to ischemic consequences.184 Neurovascu-
lar disease in PXE is characterized by intracranial 
aneurysms and cerebral ischemia caused by pre-
mature arterial occlusive disease.257
Neurofibromatosis type 1
Even though neurofibromatosis type 1 (NF-1) 
is mainly defined by neurocutaneous findings, 
this syndrome is associated with severe abnor-
malities of bones, arteries, and veins.185,202,244 
Intracranial occlusive arterial disease is the 
most common neurovascular manifestation of 
neurofibromatosis, followed by cervical arte-
riovenous fistulae and aneurysms and intra-
cranial aneurysms.257 In a retrospective analy-
sis of 22 adult patients with NF-1 undergoing 
head MRI, incidental intracranial aneurysms 
were detected in 9%.261 In a review article of 
316 patients with NF-1 who underwent brain 
MRI, 8 children (2.5%)  were reported to have 
an abnormality of the cerebrovascular system, 
including narrowed or ectatic vessels, vascular 
stenoses, aneurysm, and moyamoya.244 Intra-
cranial aneurysms in pediatric NF-1 patients 
are rarely reported.47 In fact, in an autopsy 
study with neuropathological investigation of 
25 NF-1 patients no intracranial aneurysms 
were found.34 
Fibromuscular dysplasia
Fibromuscular dysplasia (FMD) is an uncom-
mon, segmental, nonatherosclerotic, and 
noninflammatory arterial disease of unknown 
etiology.297 It commonly affects the renal and 
cervical internal carotid arteries and some-
times the vertebral arteries.129 Although often 
asymptomatic, FMD can also be associated 
with spontaneous dissection, severe stenosis, 
and intracranial aneurysms.297 A few case re-
ports of pediatric patients with FMD and intra-
cranial aneurysms exists.201,203,213
Aortic coarctation
In a study from Mayo Clinic,259 congenital heart 
disease was diagnosed in 8% of the children 
with intracranial aneurysms. Coarctation of 
the aorta (AC) accounts for 4-8% of congeni-
tal heart diseases.24,173,195 AC is a narrowing of 
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the aorta, most commonly distal to the origin of 
the left subclavian artery, thus causing elevated 
blood pressure and hemodynamic stress to ar-
teries proximal to the coarctation. The incidence 
of AC is ca. 0.3-0.4/1000 live births,208 and ap-
proximately ten new cases are diagnosed yearly 
in Finland. The narrowing of the aorta is treated 
by open surgery or angioplasty and stenting, de-
pending on the child’s age.
 
Intracranial aneurysms are found more often in 
patients with AC than in the general population, 
and aneurysm rupture occurs much earlier in the 
lives of these patients when there is coexistent 
AC.264 The main pathobiology behind this has 
been thought to be high blood pressure in cranial 
arteries. 
2.2.3. Special characteristics of 
aneurysms in children
 
In the literature review of 871 patients, the most 
common location for aneurysm in a pediatric pa-
tient was the internal carotid artery (ICA), typical-
ly the ICA bifurcation (Figure 2). The aneurysms 
were of medium size and 65% had ruptured. Of 
vertebrobasilar artery aneurysms in children, the 
most common locations are the midbasilar trunk 
(31%) and basilar bifurcation (16%).40
2.2.3.1.Size, location, and number of 
aneurysms
Intracranial aneurysms are divided into four 
groups according to size; small aneurysms have 
a diameter of under 5 mm, medium-sized aneu-
rysms 6-15 mm, large aneurysms 16-24 mm and 
giant aneurysms 25 mm or more. Among pediat-
ric aneurysm patients, the tendency for giant an-
eurysms in series from the 1980s was reported to 
be high, between 20% and 54%.64,193,284 However, 
recent patient series report much lower propor-
tions of giant aneurysms, 0-14%,110,135,225 with the 
exception of a large series from a tertiary referral 
center (22%).117 Multiple aneurysms are uncom-
mon among pediatric aneurysm patients.1 In the 
literature review, aneurysms were multiple in 0-
14% of cases, which is lower than that reported 
for adult patients (15%-28%).100,142,312 A recent 
study of  adult aneurysm patients in Finland re-
ported that ruptured and unruptured aneurysms 
have different location distributions.100 
2.2.3.2. Etiology
In adult series, the majority of intracranial an-
eurysms are considered idiopathic. In pediatric 
patients, traumatic and infectious aneurysms are 
more common than in adult patients. Roughly 
30% of aneurysms in children are idiopathic, 
50% are related to arterial dissection, and 15% 
are associated with infection.134 About 5-10% are 
related to head trauma.134 
FIGURE 2.
Typical locations of aneurysms with proportions 
of pediatric aneurysm patients of the reported 
patient series described in Table 1. ACoA= an-
terior communicating artery, BA = basilar artery, 
ICA bif = internal cerebral artery bifurcation, 
MCA=middle cerebral artery, PCoA =posterior 













Dissecting aneurysms are common among pe-
diatric aneurysm patients. Pediatric patients 
account for about 7% of all intracranial arte-
rial dissections.258 In a review of intracranial 
aneurysms in children, 45% were reported as 
dissections.159 However, pediatric patients with 
dissecting aneurysms usually present with 
ischemia rather than hemorrhage.162 In pediat-
ric dissecting aneurysms with local lesion and 
evidence of mural hematoma, spontaneous 
healing is regularly observed and conservative 
treatment is thus recommended.159 
Traumatic aneurysms
Traumatic aneurysms are a result of a head 
trauma, either penetrating or non-penetrating. 
Penetrating injuries may cause direct injury to 
the artery.76,91,128,194 Traumatic aneurysms as a 
result of closed head injury without direct in-
jury to the arteries are caused by acceleration 
forces, usually rotational, resulting in shear 
stress of the artery wall. Some of the aneu-
rysms regarded as traumatic aneurysms are 
actually false aneurysms, or pseudoaneurysms, 
which are caused by the rupture of entire ves-
sel wall layers.210 In these cases, the angio-
graphically visible aneurysm is usually only ex-
travasation of contrast media and the walls of 
the “aneurysm” are formed by the surrounding 
cerebral structures. In a true traumatic aneu-
rysm, the walls of the aneurysm sac resemble 
that of an idiopathic aneurysm, i.e. the intima, 
internal elastic lamina, and media layers are 
disrupted, but the adventitia is intact.194 The 
most common locations of traumatic aneu-
rysms are the base of the skull, typically involv-
ing the petrous, cavernous, or supraclinoid ICA 
or peripheral branches of the anterior cerebral 
artery (ACA).21 Traumatic distal ACA aneurysms 
are secondary to trauma against the falcine 
edge. Also distal cortical artery aneurysms as-
sociated with an overlying skull fracture have 
been reported.21 
The reported risk of hemorrhage in posttrau-
matic aneurysms is 19-60%,6,21 with an associ-
ated mortality rate of 31-54%.6,55,214 The hem-
orrhage from a ruptured traumatic aneurysm 
typically presents 2–4 weeks after the initial 
head trauma.134 Traumatic aneurysms com-
prise less than 1% of all intracranial aneurysms, 
but 25–75% of traumatic aneurysms occur in 
patients aged under 18 years.314 A rare cause 
of traumatic aneurysms in a young child is bat-
tery (i.e. shaken baby syndrome).155,170 Piatt and 
Clunie219 reported a superior cerebellar artery 
aneurysm as a result of a birth trauma with pre-
cipitous delivery causing stretching of the ten-
torium, thus causing vascular trauma. 
AVM-related aneurysms
One to two percent of patients with intracra-
nial aneurysms also have an AVM,40 and of the 
patients with an AVM 16-25% have an associ-
ated aneurysm.40,181 If a patient with both an 
aneurysm and an AVM presents with SAH, in 
two-thirds the aneurysm has ruptured.40 AVM-
related aneurysms are graded based on their 
relationship to the nidus and feeding artery. 
These aneurysms usually develop on the main 
feeding arteries of the AVM due to hemody-
namic stress. Flow-related aneurysms coexist-
ing with cerebral AVMs frequently are associ-
ated with initial hemorrhage presentation.181 In 
most cases, treatment of the AVM will eventu-
ally lead to disappearance of the aneurysm.
Mycotic aneurysms
Infectious aneurysms, traditionally called  my-
cotic aneurysms, comprise both bacterial and 
fungal infections. The suggested pathomecha-
nism by which a pathogen in the bloodstream 
is able to cause an aneurysm is that bacteria 
from septic emboli escape through the vasa 
vasorum and cause severe inflammation of 
the tunica adventitia.139 The inflammation 
spreads and arterial pulsatile force weakens 
the inflamed vessel wall, finally resulting in an-
eurysm formation.139 Mycotic aneurysms ac-
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In autopsy studies of adults, the prevalence of 
cerebral aneurysms is between 1.6 and 4 per 
1000 persons.233 To date, no studies on the 
true incidence of pediatric aneurysms have 
emerged. 
2.3.2. Special characteristics of 
SAH in children
2.3.2.1. Rebleeding
Of the overall SAH population, about 9% of 
patients suffer from a rebleed.177 Rebleeding is 
the major factor causing mortality and morbid-
ity among SAH patients,190 and has been asso-
ciated with such complications as hyponatre-
mia, respiratory failure, and hydrocephalus.177 
Rebleeding is particularly common in the pedi-
atric SAH population, partly due to the rarity of 
this disease in this age group causing a delay in 
diagnosis.225 Rebleeding rates of up to 52% in 
pediatric SAH patients have been reported.225 
Rebleeding often occurs within 6–24 hours af-
ter the initial bleeding.123, 177 
Rebleedings are prevented by total bed rest 
of the patient until the aneurysm has been 
secured (preferable within 24-48 hours) and 
subsequent management of blood pressure. 
An antifibrinolytic agent, mainly tranexamic 
acid, is used for SAH patients with unsecured 
aneurysms until day three from the bleeding 
to prolong the formation of a clot inside the 
ruptured aneurysm.56
2.3.2.2. Hydrocephalus
Hydrocephalus occurs in approximately 20-
30% of SAH patients. The onset of hydroceph-
alus can be acute, within 48 hours of SAH, or 
chronic (i.e. late onset), occurring weeks and 
even months after the hemorrhage. Acute hy-
drocephalus is diagnosed in about 18-20% of 
count for 1-7% of all intracranial aneurysms121 
and carry a high-mortality rate when they rup-
ture.139 Mycotic aneurysms are typically small 
and located in the terminal branches. In the lit-
erature review with 871 pediatric patients, 52 
mycotic aneurysms were present among a to-
tal of 949 aneurysms, yielding a proportion of 
5.5%. Almost all patients with a bacterial aneu-
rysm have vegetative endocarditis. There are 
some reports of HIV-related arterial angiopa-
thies41,140 and cerebral aneurysms in pediatric 
patients.182 Other viral infections, e.g. varicella 
zoster or cytomegalovirus of the vasculature, 
mainly cause vasculitis.
2.2.3.3. Presentation
The majority of ruptured aneurysms in children 
present with SAH,110 and 7% present with ICH 
only.110 Unruptured giant aneurysms typically 
present with epileptic seizures, cranial nerve 
deficits, or neurologic symptoms.
2.3. Aneurysmal SAH in 
childhood
2.3.1. Incidence of aneurysmal SAH 
in children
In a population-based study with 2.3 million 
children aged under 20 years, the incidence of 
spontaneous hemorrhagic stroke was 1.4/100 
000 person-years.110 Of these patients, 13% had 
cerebral aneurysms thus yielding an incidence 
of 0.18/100 000 person-years for aneurysmal 
hemorrhagic stroke in childhood and adoles-
cence.110 According to the same study, the inci-
dence was higher, 0.52/100 000 person-years, 
in children aged 15-19 years compared with 
those aged 0-14 years, 0.06-0.09/100 000 per-
son-years.110




SAH patients.179,311 Hydrocephalus can be ob-
structive due to a blood clot inside the ventric-
ular system preventing normal cerebrospinal 
fluid (CSF) circulation, while in communicating 
hydrocephalus the blockage of CSF is in the 
subarachnoid space.131 Correlations between 
chronic hydrocephalus and admission Hunt & 
Hess grades (see Appendix I) and Fisher grades 
(see Appendix I) have been reported,308 where-
as timing of surgery292 and treatment modality 
for aneurysms, i.e. clipping versus coiling, were 
not risk factors.269 Overall, 9-20% of patients 
develop chronic hydrocephalus demanding 
shunting.141,308 
In children, compliance of the brain to the ex-
tra volume demand caused by the arrest in CSF 
circulation is lower than in adults. Thus, symp-
toms of hydrocephalus occur more rapidly.
The treatment of acute hydrocephalus is extra-
ventricular drainage (EVD). Chronic post SAH 
hydrocephalus is treated with shunting. 
2.3.2.3. Vasospasm
Blood outside of an artery or in the  CSF  causes 
the smooth muscle cells of the tunica media to 
contract, thus narrowing the arterial lumen, 
i.e. causing vasospasm.318 The change in the 
caliber of the vessel is to some degree com-
pensated by an increase in blood velocity. The 
blood supply to cerebral tissue is eventually 
compromised and delayed neurologic symp-
toms occur. A recent publication, however, 
challenges this reasoning, proposing that the 
arterial narrowing is not the only cause of de-
layed clinical deterioration and that the entire 
picture of delayed clinical deterioration may 
be multifactorial, including early brain injury 
and cortical spreading depression, with all of 
these factors contributing to overall mortality 
and morbidity.221 Vasospasm is usually divided 
into angiographic vasospasm and clinical va-
sospasm, the latter sometimes also called de-
layed ischemic neurologic deficit (DIND); and 
occasionally leading to delayed cerebral infarct 
(DCI).177 The highest incidence of vasospasm is 
between the fourth and eleventh posthemor-
rhage day.318 Among adult SAH patients, angio-
graphic vasospasm is diagnosed in about 45% 
and DIND in about 20% of patients.246 Approxi-
mately 30% of patients develop DCI.317 Risk 
factors for the development of symptomatic 
vasospasm include a large-volume, persistent 
subarachnoid clot,227,334 as well as poor neuro-
logical condition on admission, smoking, and 
hypertension.51 
Computed tomography angiography (CTA), 
digital subtraction angiography (DSA), and 
transcranial Doppler (TCD) are widely used to 
monitor the temporal course of vasospasm. 
Treatment of vasospasm consists of calcium 
channel blocker agent (nimodipine) and classic 
triple-H-treatment (hypertension, hemodilu-
tion, and hypervolemia). Novel techniques in 
severe vasospasm include endovascular tech-
niques such as balloon angioplasty and intra-
arterial infusion of vasodilatators.175,199
In an adult SAH study from St. Louis, vaso-
spasm was associated with younger age (<50 
years),119 however, in another study246 no dif-
ferences between ages were found among 
adult SAH patients. Among pediatric patients, 
symptomatic vasospasm is rare.160,225 An expla-
nation for this may be the greater potential of 
leptomeningeal collateral circulation among 
children.159 The leptomeningeal collateral cir-
culation, i.e. leptomeningeal anastomoses, is 
the collection of pial arteries that are connect 
branches between two major cerebral arteries 
supplying two different cortical territories.19 
These are also called secondary collaterals, in 
contrast to primary collaterals (arteries in the 
Circle of Willis).172,192 The age of the patient is 
an independent factor in the compensatory 
capacity of leptomeningeal anastomosis, pos-
sibly due to manifestation of atherosclerosis 
in older vessels.19 There is interindividual vari-
ability in leptomeningeal collateral size, num-
ber, and localization.19 The clinical meaning of 
these secondary collaterals is mainly discussed 
in management and outcome after cerebral 
stroke. The methods used to grade the efficacy 
of this circulation have yet to be assessed.192 
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2.4. Treatment of 
aneurysms in children
Treatment of intracranial aneurysms aims to 
exclude the whole aneurysm from the blood-
stream without sacrificing normal blood sup-
ply. A ruptured aneurysm should be treated 
as soon as possible to eliminate the risk of re-
bleeding. Among adult series, a debate exists 
about the natural history of small unruptured 
aneurysms.28,114,232 A large multicenter study 
(International Study of Unruptured Intracra-
nial Aneurysms, ISUIA) came to the conclu-
sion that unruptured aneurysms of 7 mm or 
smaller should not be surgically treated.104,324 
ISUIA has been criticized for recruitment and 
selection bias.11,283 Intracranial aneurysms in 
children are a different focus. The long lifes-
pan expected for a child is a factor advocating 
an active and enduring treatment. 
2.4.1. Observation 
Conservative treatment for a ruptured aneu-
rysm is not an option in modern medicine. In 
the 1940s and 1950s, operative mortality was 
high and the risk related to anesthesia was not 
inconsiderable. Also patients were not oper-
ated on immediately; bed rest of 2-3 weeks 
was recommended after SAH to improve op-
erative conditions, i.e. diminish brain swelling. 
In many cases, the Hunt & Hess scale (see Ap-
pendix I) improved, but at a cost of rebleed-
ings during the waiting period. 
A study from the late 1970s stated that in the 
first six months after SAH at least 50% of pa-
tients with untreated artery aneurysms will 
rebleed; however, if the patient survives the 
first six months the natural history of their 
ruptured aneurysms will resemble that of un-
ruptured ones.107 
2.4.2. Microsurgery
Surgical treatment of aneurysms is varied, 
including such options as clipping, proximal 
occlusion with or without bypass, trapping, 
and wrapping (Figure 3). The most common 
surgical procedure is to clip or ligate the neck 
of the aneurysm (Figure 3 A). The ligation was 
formely done with a linen knot, today with a 
string clip, which comes in variable sizes and 
forms. In trapping (Figure 3 B), the aneurysm 
is treated by occlusion of the parent and dis-
tal arteries. With this method, the aneurysm 
can be fully excluded from the bloodstream; 
however, the parent artery is sacrificed. Wrap-
ping is a method in which the aneurysm is 
strengthened by wrapping a piece of muscle, 
fascia, or cotton around the aneurysm with or 
without a clip (Figure 3 C). The parent artery is 
spared; however, the risk of rupture of the an-
eurysm might not be completely eliminated. 
Aneurysm can also be treated by occlusion of 
the parent artery proximal to the aneurysm 
either extra- or intracranially. In extracranial 
occlusion, the common carotid artery (CCA) 
or ICA is occluded by a stitch, clip, or instru-
ment, e.g. Crutchfield® instrument, where oc-
clusion of the artery can be performed while 
the patient is awake, thus inspecting possible 
neurological deficits. However, occlusion of 
ICA is a risk factor for subsequent de novo an-
eurysm formation.237 With the aid of a bypass 
graft, the blood flow is secured by providing 
a detour. Complex aneurysms might need a 
bypass operation combined with proximal 
ligation. In the excimer laser-assisted nonoc-
clusive anastomosis (ELANA) technique, large-
caliber bypass revascularization is possible 
without temporary occlusion of the parent ar-
tery.16,156,285 Bypasses usually need antiplatelet 
medication to prevent thrombosis of the by-
pass. The thrombosis of a bypass vessel is also 
a risk when the flow-dynamics do not match,4 
and in aneurysm surgery bypass operations 
are usually accompanied by proximal occlu-
sion.





Examples of microsurgical occlusion methods for aneurysms; clipping (A), trapping (B), clip-aided 
wrapping (C).
2.4.2.1. Patient series
In the literature review, the majority of pediat-
ric patients with intracranial aneurysms were 
treated microsurgically. 
2.4.3. Endovascular treatment
In endovascular treatment, the aneurysm is 
excluded from the bloodstream using intra-
arterial techniques. Soviet neurosurgeon and 
member of the Burdenko Neurosurgery Insti-
tute Fedor A. Serbinenko can be regarded as 
the father of endovascular neurosurgery.294 
He invented and perfected the technique of 
balloon embolization,268 which revolutionized 
the practice of endovascular surgery. Nowa-
days, Guglielmi detachable platinum coils 
(GDC®s)73,74 and occasionally stents and bal-
loons are used in the procedure. Coils are de-
tached from the guiding wire by electrical cur-
rent, which in turn is believed to enhance the 
thrombosis of the aneurysm. The aneurysm 
sac is filled with platinum coils. Occasionally, 
when coiling a broad-neck aneurysm, stents 
or balloons are used. Intra-arterial stents re-
quire life-long antiplatelet medication. More-
over, migration of the coils or stent outside 
the lumen has been described.38,138 Also, in the 
long run, coil impaction resulting in aneurysm 
recurrence is a recognized problem.197,198,230 
Therefore, angiographic follow-up, most often 
with magnetic resonance angiography (MRA), 
is advised. Coil impaction might require addi-
tional treatment of the aneurysm; however, 
with pre-existing coils, the treatment is chal-
lenging.239
Diagnostic angiography itself carries a risk for 
thromboembolic complications, dissection, in-
guinal pseudoaneurysm, and groin hematoma. 
The frequency of all neurologic complications 
is 0.45-2.3%72,163 and the frequency of persis-
tent neurologic deficits is 0.09-0.4%.72,163 In 
one study, non-neurologic complications were 
observed in 14.7% of the examinations.163 
In a study with 241 diagnostic DSA in children, 
there were no intraprocedureal complications; 
however, one child with a complex dural arte-
riovenous fistula experienced a fatal intracra-
nial rehemorrhage secondary to a posterior 
fossa varix rupture 3 hours after the diagnostic 
angiogram, yielding a  postprocedural compli-
cation rate of 0.4%.23
2.4.3.1. Radiation dose
There is no safe limit when considering the 
radiation dose to living tissue. Effects of ra-
diation on tissue are cumulative; therefore, 
the ALARA (As Low As Reasonably Achiev-
able) concept is used. The unit describing 
biological effectiveness of ionizing radia-
A B C
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tion is Sievert [Sv]. Energy deposited in the 
target (absorber) is described as absorbed 
dose (unit Gray [Gy]). Different tissues tol-
erate radiation in different ways. The doses 
in radiological studies have become small-
er within the last 40 years. The absorbed 
doses in different radiological studies and 
interventions used in treating of intracra-
nial aneurysms are presented in Table 4. 
In a recent phantom study,187 the effective 
dose for CTA assessment of cerebral ves-
sels was approximately one-fifth the dose 
for DSA. The younger the patient, the most 
vulnerable the tissue is to radiation. Expo-
sure to high doses of radiation at a younger 
age carries a risk for leukemia217 and intra-
cranial tumors, especially meningiomas. 
Meningiomas have been reported to occur 
after radiation doses of 1800 cGy.29 At very 
high doses, over 4000-5000 cGy, there is 
a risk of radiation-induced leukoencepha-
lopathy.39 Even though these doses are far 
higher than the doses in the diagnosis and 
endovascular treatment of cerebral aneu-
rysms, the threshold for radiation-induced 









Radiation doses (in Gray [Gy]) for common ra-
diological procedures in the cerebrovascular 
diagnosis and treatment of cerebrovascular 
lesions in pediatric patients. CT=computed to-
mography, CTA=computed tomography angi-
ography, DSA=digital subtraction angiography.
2.4.4. Multidisciplinary collaboration
Intracranial aneurysms in children are often 
complex, requiring multidisciplinary work be-
tween neurosurgeons and neuroradiologists. 
As stated by Sanai et al.,249 “Nowhere in neu-
rosurgery is there a clearer need for neurosur-
geons and neurointerventionalists to work in 
specialized teams than with the pediatric an-
eurysm patient“.
2.5. Outcome
Kassell et al.124 stated over twenty years ago 
that “the study of factors affecting morbidity 
and mortality is essential in effectively plan-
ning, developing, and evaluating therapeutic 
methods for improving the outcome in pa-
tients with SAH”. Outcome of patients with a 
neurological disaster has traditionally been es-
timated and categorized by structured scales 
such as the Glasgow outcome scale (GOS)108 
and the modified Rankin Scale (mRS)48 (Tables 
5 and 6). These outcome scales are focused on 
the activities of daily living and on the man-
agement of patients with or without assis-
tance. The main emphasis in these scales is on 
independent living and on the ability to walk. 
GOS Description
1 Dead









Glasgow outcome scale (GOS).108
•for adults








No significant disability. 
Able to carry out all usual activities, despite some symptoms.
2
Slight disability. 
Able to look after own affairs without assistance, but unable to carry out all previous activities.
3
Moderate disability. 
Requires some help, but able to walk unassisted.
4
Moderately severe disability. 
Unable to attend to own bodily needs without assistance, and unable to walk unassisted.
5
Severe disability. 




Modified Rankin scale (mRS).48
It would be logical to assume that the plastic-
ity of the brain in young children might lead to 
improved outcome following SAH at an early 
age. However, studies of pediatric stroke have 
provided increasing evidence that younger 
age at time of brain insult is a predictor of 
worse outcome, particularly for the cognitive 
and neuropsychological domains.30,109,186 Heis-
kanen and Vilkki81 performed comprehensive 
neuropsychological tests on pediatric patients 
with ruptured cerebral aneurysms and di-
agnosed some cognitive deficits. A common 
feature of the deficits was an impairment of 
active retrieval and searching of memory, with 
common cognitive skills usually remaining un-
affected.81 Furthermore, in most cases these 
deficits did not affect the daily life of patients, 
and they tended to be unaware of the defi-
cits.81
2.5.1. Early outcome
In a previous study of pediatric aneurysm pa-
tients, the early clinical outcome was favorable 
(i.e. GOS≥4) in 92%.117 Early mortality varied 
between 0% and 23%.117,225,249 Treatment-relat-
ed neurological deficits were reported to occur 
in 0-7% of patients.80,249 The main factor affect-
ing early outcome was the initial hemorrhage. 
In a recent study122 from Kuopio, Finland, the 
mortality during the first three days after SAH 
was predicted by Hunt & Hess grades (see Ap-
pendix I) IV-V, ruptured aneurysm ≥ 15 mm, 
and acute subdural hematoma. According to 
the same study,122 patients in good condition 
on admission had a low mortality rate at 12 
months, regardless of age.
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2.5.2. Long-term outcome
Favorable long-term outcome in pediatric series 
has been reported in 64-100%,117,225,249 however, 
these series have variable proportions of patients 
with ruptured and unruptured aneurysms. The 
follow-up times in these studies vary between 1 
month and 18 years.
Unfavorable long-term outcome in pediatric an-
eurysm patients is associated with initial hemor-
rhage, parent artery occlusion, and vasospasm. 
This is in agreement with adult studies; the Fisher 
grade and the Hunt & Hess grade correlated with 
favorable outcomes.174 Other factors in adult pa-
tients associated with poor outcome are advanced 
age, hyperglycemia on admission, high Hunt & 
Hess grade, and larger aneurysm size.196
2.6. Long-term excess 
mortality
It has previously been thought that a SAH patient 
whose aneurysm was completely treated and who 
survived the first year after SAH would attain the 
life expectancy of the general population.205 A 
study with distal ACA aneurysms found no excess 
mortality in patients after surviving the first three 
years after SAH.167 However, among adult SAH-
patients, long-term excess mortality has been de-
scribed, being mainly due to increased incidence 
of cardiovascular deaths, followed by cerebrovas-
cular deaths.242 This is reasonable because both 
aneurysmal SAH and cardiovascular diseases share 
the same risk factors, i.e. hypertension and smok-
ing. The role of new SAH in long-term mortality has 
been modest.242 A recent study showed that after 
the initial diagnosis of cerebral aneurysm patients 
have an increased incidence of lung cancer in long-
term follow-up.99
Until this study, no studies have existed on 
long-term excess mortality among pediatric 
aneurysm patients.
2.7. Long-term radiological 
follow-up
Patients who survive SAH have a higher occurrence 
of a new SAH than the general population, even after 
successful treatment of the initial aneurysm, due to 
de novo and recurrent aneurysms.20,302,321 The an-
nual occurrence of de novo aneurysms in adult SAH 
patients has been reported to be 0.3-4%.27,36,113,321 A 
study with adult aneurysm patients showed that the 
cumulative risk of de novo aneurysm formation be-
comes significant after nine years.302 Among adult pa-
tients, the risk factors for de novo aneurysm forma-
tion are female gender, younger age, hypertension, 
multiple aneurysms at onset, and smoking.228,295,335 
In the past, carotid artery occlusion was used to treat 
ICA aneurysms that were otherwise untreatable. 
Formation of de novo aneurysms is a well-known 
late sequela of carotid occlusion.  In a review ar-
ticle,5 the risk of de novo aneurysm formation was 
4.3% in patients with previous ICA occlusion. The 
most common locations in these patients for de 
novo aneurysms are reported to be ACoA and pos-
terior communicating artery (PCoA),5,15 probably 
due to hemodynamic changes and increased flow 
from the contralateral ICA. The mean time for de 
novo aneurysm formation is 9-10 years.5,15,61 Other 
common risk factors for aneurysm formation, i.e. 
female gender, hypertension, and smoking, most 
certainly have a role in de novo aneurysm forma-
tion among patients with previous ICA occlusion.
Almost 20 years ago, Rinne and Hernesniemi237 pro-
posed that young SAH patients could benefit from 
long-term neuroradiological follow-up to screen 
and treat de novo aneurysms early. Several pediat-
ric aneurysm series advocate life-long clinical and 
minimally invasive radiological follow-up of these 
patients; however, only a few publications provide 
precise guidelines for the follow-up protocol. Sanai et 
al.250 recommended angiography 3-5 years after mi-
crosurgical therapy and 6 and 24 months after endo-
vascular therapy, with additional surveillance exami-
nations according to the findings of these studies.





2.8.1. Pediatric neurosurgery 
Pediatric neurosurgery owes most of its routine, 
techniques, and instrumentation to the 
neurosurgery of adults, but, as we know, 
there are important differences in 
scale, anatomy, physiology, and pathology.
Kenneth Till 1975
Neurosurgery was sporadically practiced 
on children from prehistoric times until the 
Harvey Cushing era.209 The history of pediatric 
neurosurgery dates back to the early 1930s, 
when dedicated general surgeons specialized in 
neurosurgery and trained neurosurgeons began 
providing tailored care for children.95 The growth 
and development of pediatric neurosurgery started 
at Boston Children’s Hospital under the direction 
of Dr. Franc Ingraham, a pupil of Cushing’s, and Dr. 
Donald Darrow Matson in the 1950s.209 Ingraham 
graduated from Harvard Medical school in 1925 
and spent three years under Cushing’s training.95 
He gained his surgical and research experience at 
John Hopkins University and Oxford University. 
Ingraham returned to Boston in 1929 and 
received Cushing’s blessing to focus on children’s 
neurosurgery. Ingraham was accompanied by a 
skilled neurosurgeon, his successor, Dr. Matson, 
and in 1954 Ingraham and Matson published 
the first textbook of pediatric neurosurgery 
“Neurosurgery of Infancy and Childhood”.94 The 
book contains information about congenital 
anomalies, hydrocephalus, trauma, intracranial 
and intraspinal tumors, infection, cerebrovascular 
disorders, epilepsy, lead encephalopathy, 
and pediatric neurosurgical anesthesia.7
Another pioneer in the field of pediatric neu-
rosurgery, Dr. Kenneth Till was the first full-time 
pediatric neurosurgeon in the UK.18 Till graduated 
from the University of Cambridge in 1944, and 
trained at Atkinson Morley’s Hospital, Wimble-
don, in South London, and at Children’s Memorial 
Hospital, Chicago, as well as in Boston with Mat-
son.18 Till was a founder member in 1972 of the 
International Society of Paediatric Neurosurgery 
(ISPN). Organization of pediatric neurosurgery 
had gradually begun and the European Society 
for Pediatric Neurosurgery (ESPN) had been es-
tablished a few years earlier, in 196795. Till pub-
lished his monography “Paediatric neurosurgery 
for paediatricians and neurosurgeons” in 1975, at 
a time when children’s neurosurgery relied heav-
ily on the personal experience of neurosurgeons. 
Today, pediatric neurosurgery is a recognized sub-
speciality in the field of neurosurgery. It exists as a 
member of the family of neurosurgery with its own 
training programs, process of accreditation, na-
tional and international conferences, and scientif-
ic journals.326 ISPN has its 40th Annual Meeting in 
2012, with 350 active members from 40 countries.
2.8.2. Pediatric neurosurgery in 
Helsinki
The Finnish Red Cross Hospital (later Töölö 
Hospital) was founded in 1932 by Marshall 
Mannerheim and his sister Sophie Manner-
heim. It served as the only neurosurgical de-
partment in Finland until 1966 (Figure 4). 
FIGURE 4.













Before the Second World War, 
general surgeons in our country were 
responsible for children’s surgery.315 
On December 1st, 1946, a young 
surgeon, Matti Sulamaa (1910-1988), 
was appointed as a resident at the 
Children´s Hospital in Helsinki.178,287 
Later, the same surgeon became the 
first chief surgeon of pediatric surgery 
at the Children’s Hospital in Helsinki. 
Professor Sulamaa can be regarded 
as a pioneer of pediatric surgery in 
Finland. He collaborated closely with 
neurosurgeons at the Finnish Red 
Cross Hospital, where he started his 
surgical career as a fellow of Professor 
Aarno Snellman in the 1930s (Figure 
5).287 Professor Snellman had 
acquainted himself with the field 
of neurosurgery at the Karolinska 
Institute at Stockholm by working 
with Professor Herbert Olivecrona 
in1935, and Professor Snellman 
can be considered the founder of 
neurosurgery in Finland.165 Professor 
Sulamaa studied hydrocephalus 
under the guidance of Professor 
Snellman.287 A young surgeon Lauri V. 
Laitinen began his surgical career at 
Children’s Hospital under the guidance 
of Professor Sulamaa before starting 
a residency in neurosurgery.287 The 
first ventriculocisternal (Torkildsen) 
shunts to treat hydrocephalus were 
implemented in Finland at the 
Finnish Red Cross Hospital (later 
Töölö Hospital) in the 1950s. The 
first modern shunt operation with 
a Spitz-Holter valve was performed 
by Dr. Laitinen in March 1960. The 
patient was a 14-year-old boy with 
a tumor in the fourth ventricle. The 
PhD thesis of Dr. Laitinen in 1956 was 
entitled “Craniosynostosis; premature 
fusion of the cranial sutures: An 
experimental, clinical and histological 
investigation with particular 
reference to the pathogenesis and 
FIGURE 5. 
Dr. Sulamaa (left) assisting Professor Snellman in a 
craniotomy at the Finnish Red Cross Hospital (later 
Töölö Hospital) in 1941 (A). Sister Laina and an over-
view of the operating room (B). The “Three Profes-
sors” performing a neurosurgical operation: Profes-
sor Troupp on the left serving as assistant, Professor 
ad Björkesten in the center as the main surgeon, and 








etiology of the disease”.143 He performed the 
first surgeries for craniosynostosis in Finland 
together with Dr. Sulamaa. Laitinen later 
established his position as an innovative 
developer of stereotactic and functional 
surgery.153,154 The neurosurgeons in Helsinki 
were active in publishing their experiences 








Unilateral coloboma nervi optici combined with a homolateral block of 
aquaeductus monro; a case report.
1954 Laitinen L
Sulamaa M148
Craniosynostosis; symptoms and results of treatment.
1955 Laitinen L
Sulamaa M149




Ophthalmological observations in craniosynostosis.
1956 Laitinen L
Sulamaa M150
Craniosynostosis; symptoms, treatment and results of treatment. II
1960 Troupp H299 Pathology, diagnosis, and treatment of supratentorial tumours in in-
fancy and childhood.
1961 Laitinen L144 Medical defects in the cerebral arteries of newborn infants.
1961 Kauhtio J
Törmä T127
Subtotal hemisphrectomy for intractable convulsive seizures.
1964 Laitinen L145 Arterial aneurysm with subarachnoid hemorrhage in children.
1965 Laitinen L152 Short-term results of stereotaxic treatment for infantile cerebral palsy.





Intracranial arterial aneurysm in a three-month-old infant. Case report.
TABLE 7. 
First publications in the 1950s and 1960s on pediatric neurosurgery in Helsinki.
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2.8.2.2. Developments in neurosurgery 
The first neurosurgical operation in Finland 
was performed by Professor Snellman after 
his return from Karolinska Institute in Septem-
ber 1935.165 The first cerebral angiographies 
were performed in 1936.178,287 At that time, 
cerebral angiographies required a surgical 
exposure of the carotid artery and were con-
sidered risky for the patient. The introduction 
of the percutaneous carotid puncture tech-
nique in 1948 gradually increased the annual 
number of these procedures, from about 20 
in 1947 to over 150 in 1949.165 Finally, in the 
1970s, Seldinger’s percutaneous transfemo-
ral route,267 originally introduced in the mid-
1950s became more common in Helsinki. 
With catheter angiography, the rate of com-
plications decreased and the accuracy of diag-
nosis increased. During the 1990s DSA as the 
preferred diagnostic tool for intracranial aneu-
rysms in SAH patients was displaced by a less 
invasive method, CTA.120
The next pediatric aneurysm patient was ad-
mitted in December 1951. The patient was an 
18-year old boy with SAH at the end of Octo-
ber 1951. The patient had two rebleedings. 
Carotid angiography showed a 10-mm right-
sided middle cerebral artery (MCA) aneurysm. 
On January 4th 1952, a craniotomy was per-
formed to ligate the aneurysm; however, the 
operation did not advance beyond the explor-
atory stage and ligation was not attempted. A 
ventriculostomy was placed. A transcript of 
the operation report is shown in Figure 6. The 
patient was discharged on January 12th 1952, 
with GOS 3. The surgeon inquired about the 
patient’s recovery a few years later; the pa-
tient reported in a letter dated May 14th 1957 
that he had fully recovered and was working 
as a logger. The patient died due to a massive 
SAH 20 years after the initial bleeding, on De-
cember 29th 1971 at the age of 38 years.
Neurosurgeon Olli Heiskanen was interested in 
pediatric neurosurgery, in both clinical practice 
and research. Dr. Heiskanen visited Dr. Matson 
in Boston and worked as his fellow during 
1965-1966, closely observing Dr. Matson´s 
work.300 Dr. Matson visited Helsinki soon after 
Heiskanen’s return and performed a pediatric 
operation in Helsinki in 1967. The patient 
was a 12-year-old boy with a teratoma in the 
pineal region. Professor Matson, Professor af 
Björkesten, and Dr. Heiskanen extirpated the 
tumor on December 27th 1967; however, the 
patient was reoperated on three days later 
due to postoperative epidural hematoma. 
Dr. Heiskanen later worked at Children’s 
Hospital with Dr. Sulamaa. After returning to 
Töölö Hospital, he served as the consulting 
pediatric neurosurgeon for 25 years, and 
from 1972 onwards operated on all pediatric 
neurosurgical patients.300
2.8.2.1. First pediatric aneurysm patients 
The first patient with an intracranial aneurysm 
was treated in Helsinki in 1937. The first 
pediatric patient with intracranial aneurysm 
was admitted in 1943. The patient was an 
18-year-old girl. The patient presented with 
a thunderclap headache on October 1st 1943, 
followed by meningmus. The headaches 
continued and were accompanied by vertigo 
and nightly nausea and vomiting. The patient 
was examined by an ophthalmologist due to 
blurred vision. The ophthalmologist diagnosed 
bilateral papil edema, and patient was 
admitted to the Department of Neurosurgery 
on December 27th 1943. On admission, a 
mild right-sided clumsiness and balance 
difficulties were diagnosed. Bilateral carotid 
angiographies were performed, revealing a 
7-mm right-sided ICA bifurcation aneurysm. 
The aneurysm was considered inoperable and 
the patient was discharged with a good early 
neurological outcome (GOS 4). The patient 
died in June 1945 due to re-bleeding. 





Transcript of the operation report of the first pediatric aneurysm surgery in Finland on January 4th 
1952. Translation of the report (original in Finnish):
Entry through a left-sided frontal opening. Distension is very strong but reduces to some 
extent after frontal left-sided ventricular punction. After this the deeper entry is through 
the anterior surface of left frontal lobe. It is noticed that the arachnoid on the surface 
of the brain is opaque to some extent. CSF is not evident on the anterior surface of the 
frontal lobe or in the cisterns, making the exploration extremely difficult. Apparently, as a 
congenital anomaly there are two strong veins passing on the anterior-lateral surface of 
the frontal lobe in sagittal direction. The beginning of Sylvian Fissure is reached without 
finding hematoma or anything suggesting to it. Because CSF is not noted, it is assumed 
that there is a blockade around bulbus thus preventing the passage of CSF to the convex-
ity. Typical closure in layers. Skin is closed with silk and a rubber tube is inserted to the 
wound.
4th January 1952. Craniotomia explorativa (Novoc.) Prof. Snellman-Tola-Karatau-Nurse Laina.
The two World Wars have had a major im-
pact on the development of neurosurgery in 
Finland. During World War II the Red Cross 
Hospital served as the War Hospital. The large 
number of head injuries increased the need 
for neurosurgical skills, and many foreign vol-
unteer surgeons worked at the hospital. Two 
years after the end of the war in 1947, Aarno 
Snellman was appointed the first Professor in 
Neurosurgery in Finland, and the era of neu-
rosurgery in Finland had officially started. 
However, in the early years the neurosurgical 
resources were limited.
 
From the 1930s paramedics, diagnostics, 
medical treatment, surgical equipment, and 
surgical skills in the field of neurosurgery have 
developed enormously. SAH was diagnosed by 
lumbar puncture at the Department of Neuro-
surgery in Helsinki until the first computed to-
mography (CT) scan became available in 1977 
(J. Hernesniemi, personal communication).164 
In the early years, aneurysms were ligated 
with linen or silk thread ligature (Figure 7) or 
silver clips, until  spring clips became available 
in the 1960s.151 The hospital’s operative re-
cords show that wrapping, trapping, and prox-
imal occlusions were frequently used. The use 




Ligating a ruptured right-
sided internal carotid 
artery (ICA) bifurcation 
aneurysm in an 18-
year-old girl with a linen 
thread, as illustrated by 
Professor af Björkesten 
in 1955 (A), with preop-
erative (B) and postop-
erative angiography (C). 
A control angiography in 
2011, 56 years after the 
initial treatment showed 
the ICA aneurysm and a 
de novo aneurysm at the 
right posterior commu-
nicating artery (PCoA) 
(D). The patient had a 
new SAH from the left-
sided PCoA 25 years 









Introduction of the operating microscope initi-
ated the era of microsurgery.330 A Turkish born 
neurosurgeon Davut Tovi from Umeå, Swe-
den, demonstrated the use of an operating 
microscope in the operating room in Helsinki 
in January 1975.164 The first operating micro-
scope became available in Helsinki in  1975.164 
It was introduced into clinical practice by se-
nior neurosurgeons no thorough training in its 
use. Professor Juha Hernesniemi operated on 
his first aneurysm in 1976, and has since then 
operated on nearly 4000 aneurysms, all under 
the microscope.165
Together with advances in surgical equipment, 
medical treatment has taken great strides 
forward. Progress in neuroanesthesia has 
had an impact on intensive care management 
of neurosurgical patients. Active secondary 
prevention with invasive patient monitoring 
has superseded the formerly more passive 
“wait and see”-approach.165 The calcium 
channel antagonist nimodipine was introduced 
in the late 1980s and has been routinely used 
in Helsinki ever since.338 Also the timing of 
surgery after SAH has changed from late 
to early.58,338 The treatment of unruptured 
aneurysms in Helsinki began in the 1980s. Due 
to these advances and improved management 
of patients with SAH, a slight decrease in the 
case-fatality rate of SAH during the last three 
decades has been reported.90 Initial bleeding 
from a ruptured aneurysm is fatal in 12-
15% of cases before the patient reaches the 
hospital,90,93,211,222,262 and another 15% will not 
recover from the initial bleed. The proportion 
of patients with SAH who will profit from new 
medical and surgical advances is, therefore, 
not high.90 Nevertheless, the proportion 
of patients who remain independent has 
increased and the quality of life of survivors is 
significantly better.58,176
Today, up to 3200 neurosurgical operations, 
including about 300 aneurysm patients, are 
performed yearly at the Department of Neu-
rosurgery in Helsinki. It is the largest neuro-
surgical center in Finland, with a catchment 
area of nearly 1.8 million people. 
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3. Aims of the study
1. To clarify the special characteristics of pediatric cerebral aneurysms
2. To perform a long-term clinical and angiographic follow-up of patients with
  cerebral aneurysm in childhood and to identify risk factors for developing 
 new aneurysms and new SAH
3. To assess long-term excess-mortality and to evaluate factors affecting 
 morbidity and mortality of pediatric patients with cerebral aneurysms






4. Materials and 
methods
This study is based on the data from the pedi-
atric patients admitted to the Department of 
Neurosurgery, HUCH, between 1937 and 2009. 
All patients aged 18 years or younger, excluding 
those  with AVM-related aneurysms or  vein of 
Galen malformations,  were included. Some of 
this patient material has been previously pub-
lished, in 1981 and 1989. 80,81
4.1. Publication I: 
Long-term outcome
4.1.1.Patients
In publication I, a retrospective analysis of 
114 pediatric (≤ 18 years) intracranial aneu-
rysm patients admitted to the Department of 
Neurosurgery, HUCH, between 1937 and 2009 
was performed. Hospital records and available 
radiological examinations were analyzed. The 
diagnosis of SAH was assessed if there were 
signs of bleeding either in lumbar puncture 
or CT, or if there was a clear history of sudden 
severe headache, and a bleeding could not be 
ruled out. Initial Hunt & Hess classifications (all 
patients) and the Fisher grade54 (when CT avail-
able; n=9) were used. Aneurysm(s) were diag-
nosed by conventional angiography (n=113) 
and/or CT-angiography (n=3) and/or MR-an-
giography (n=5). Postoperative occlusion sta-
tus was verified by conventional angiography 
(n=72) or CT-angiography (n=2). In cases where 
the original angiographies were not available 
(earlier years of our series), the reports of the 
neuroradiologist were analyzed. GOS was used 
to assess clinical outcome.108 
4.1.2. Follow-up
The latest clinical outcome was obtained by a 
new follow-up, a written questionnaire (see 
Appendix II). The questionnaire had questions 
about patients’ general health and underlying 
medical condition, detailed neurological symp-
toms, smoking habits and previous smoking, 
education and employment, diagnosis of new 
cerebral aneurysms or hemorrhagias, family 
history of aneurysms, diagnosis of connective 
tissue disorders, family history of connective tis-
sue disorders, and current medication. Outcome 
was defined by using GOS and mRS, and patients 
were asked about activities of daily living and 
degree of independence in daily activities.
4.1.3. Statistical methods
Statistical analyses were performed by using 
commercial SPSS software (version 19.0; SPSS 
Inc., Chicago, IL, USA). The Pearson χ2 –test and 
Linear-by-Linear Association tests were used 
when appropriate. A probability value < 0.05 
was considered statistically significant. 
4.2. Publication II: 
Long-term excess mortality
4.2.1. Patients
In contrast to publication I, in publication II pa-
tients with traumatic aneurysms (n=10) and 
foreign patients (n=2) were excluded. Data col-
lected retrospectively were in concordance with 
the data collection in publication I. Aneurysm 
treatment methods were categorized as active 
(i.e. surgical or endovascular) or conservative. 
The aneurysms in the conservatively treated 
category were not subject to any surgical or en-
dovascular treatments (or treatment attempts) 
during the entire follow-up. An aneurysm was 
considered partially occluded if there was any 
filling in the postoperative angiograms.
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RSRs and CIs were determined from one year 
after the admission to Department of Neuro-
surgery, HUCH, using R environment for sta-
tistical computing and graphics.293 
The Pearson χ2 –test and Student’s t-test 
were used to find associations between dif-
ferent patient and aneurysm characteristics 
when appropriate. Statistical analyses were 
performed using a commercial software (IBM 
SPSS Inc., version 19.0, Chicago, IL, USA). A 
probability value < 0.05 was considered sta-
tistically significant. 
4.3. Publication III: 
De novo- and 
recurrent aneurysms
4.3.1. Patients
In concordance with publication II, foreign 
patients and patients with traumatic aneu-
rysms were excluded. 
4.3.2. Follow-up
The long-term follow-up studies with cerebral 
angiographies were carried out at twenty re-
ferral hospitals in Finland during 1978-2012. 
The data were collected from these referring 
hospitals with the permission of the National 
Institute for Health and Welfare. All medical 
records from all specialties from other hos-
pitals were evaluated. The new radiological 
studies were re-analyzed by a radiologist. 
Death certificates (Statistics Finland) and au-
topsy reports for the deceased patients were 
reviewed. 
4.2.2. Data collection 
during follow-up
Patients were followed from diagnosis until 
death or the end of the year 2010. The vi-
tal status of patients (deceased or alive) at 
the end of the year 2010 was obtained from 
the Finnish Population Register Center. Two 
patients had moved abroad and were lost to 
long-term follow-up. Autopsy reports for pa-
tients who died during hospitalization were 
available. Statistics Finland provided the 
death certificates of all deceased patients 
(n=23). Death certificates contain the dates 
of death and the main cause of death, im-
mediate cause of death, and intermediate 
stages as well as a short description of the 
fatal events. Statistics Finland also provided 
comparable data on the general Finnish pop-
ulation regarding expected survival. Death 
was considered aneurysm-related if it was 
attributable to the aneurysm or its treatment 
or to late sequelae of aneurysm-associated 
morbidity, e.g. pneumonia in a bedridden 
patient paralyzed by the initial SAH. 
4.2.3. Statistical methods 
Relative survival ratios (RSRs) were calculated 
compared with the matched (gender, age, cal-
endar time) catchment population. RSRs pro-
vided a measure of excess mortality irrespec-
tive of whether this mortality was directly or 
indirectly attributable to the aneurysm itself. 
The RSR is a ratio of the observed survival 
proportion of patients to the expected one 
in a comparable reference population.44 The 
expected survival was derived using Hakulin-
en’s method77,78 from that of the comparable 
general population of Finland matched with 
respect to age, sex, and calendar time based 
on data from Statistics Finland. The confi-
dence intervals (CIs) were constructed on 
the log cumulative hazard scale and the vari-
ance of the observed survival proportion was 
estimated using “Greenwood’s method”.70,118 






The Pearson χ2 –test and Mann-Whitney U-
test were used when appropriate. Uncondi-
tional binary logistic regression analysis with 
a stepwise forward elimination procedure was 
used to calculate odds ratios (ORs) and 95% 
CIs of independent risk factors associated with 
new aneurysm formation. Annual rates of for-
mation of de novo and recurrent aneurysms 
and a new SAH were calculated by dividing the 
number of new clinical or angiographic find-
ings by the number of patient follow-up years 
assuming a linear risk throughout the follow-
up period. Cumulative rate of new SAH was es-
timated using the Kaplan-Meier product-limit 
method, and the resulting curves were com-
pared using the log-rank test. The Cox propor-
tional hazards model with a forward stepwise 
regression procedure was used to determine 
independent risk factors and relative risks 
(hazard ratio) for a new SAH. Tested risk fac-
tors were age at onset, gender, duration of fol-
low-up, current or previous smoking, rupture 
status of the initial aneurysm, family history 
for intracranial aneurysms, presence of mul-
tiple aneurysms initially, and antihypertensive 
medication. Statistical analysis was performed 
using SPSS software (version 19.0; SPSS Inc., 
Chicago, IL, USA). Probability value < 0.05 was 
considered statistically significant.
4.4. Ethical aspects
The study protocol was approved by the eth-
ics committee of HUCH. Written informed 
consent was obtained from all patients par-
ticipating in the new follow-up study in publi-
cation I. Death certificates were obtained with 
permission of Statistics Finland. Long-term 
follow-up patient records and angiographies 
were obtained from the referring hospitals 
with permission of the National Institute for 
Health and Welfare. 
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FIGURE 8.
Proportion of pediatric cerebral aneurysm patients of all aneurysm patients admitted to the Depart-
ment of Neurosurgery during 1937-2009.
5. Results
5.1. Incidence of pediatric 
aneurysms
During 1937-2009 altogether 114 pediat-
ric patients (1.3% of all 8996 aneurysm pa-
tients treated during this time period) with 
intracranial aneurysms were treated at 
the Department of Neurosurgery, HUCH. 
The proportion of these patients has di-
minished over the last decades (Figure 8).
5.2. Patient characteristics
The patient populations in the three parts 
of this study are overlapping (Table 8).
5.2.1. Age and gender
The mean age of patients was 14.5 years (me-
dian 16.1 yrs, range 3 months -18 yrs) (Table 
8 and Figure 9). At the time of diagnosis, 14 
patients were younger than 10 years, includ-
ing four patients with traumatic aneurysms. 
The majority of the patients were boys (3:2). 
5.2.2. Predisposing factors
In our series, no classical systemic collagenous 
vasculopathies were diagnosed. However, ten 
patients were diagnosed with a predisposing 
factor for intracranial aneurysms (Table 9). One 
6-year-old boy had ADPKD and another (a 6-
year-old boy) had tuberous sclerosis complex 
together with aortic stenosis. Four patients had 
congenital heart diseases; three patients (14- 
and 17-year-old boys and a 15-year-old girl) 
had coarctation of the aorta and one patient 
(a 16-year-old boy) a hypoplastic aortic wall. 
All of the heart diseases were undiagnosed 
and untreated at the time of SAH, resulting in 
hypertension on admission. Ten patients had 
a recent history of high-energy head trauma.
One patient had a family history of aneurysms 
in first-degree relatives at the time of admis-
sion and 13 were reported later (new follow-
up; questionnaire) was available for 64 of 74 
patients), yielding a total of 14 (12 %) patients 
with a family history  of aneurysms. One patient 
had a history of alcohol abuse (a 17-year-old 
boy), and altogether 10 patients were smokers 






















Patient characteristics in Studies I-III.
Study I Study II Study III
No. of patients 114 102 (88 1-year-survivors) 59
Gender
Boys (%) 69 (61%) 53 (60%) 36 (61%)
Girls (%) 45 (39%) 35 (40%) 23 (39%)
Age
Mean(years) 14.5 15.0 16.0
Aneurysms
Ruptured (%) 89 (78%) 77 (88%) 52 (88%)
Unruptured (%) 25 (22%) 11 (12%) 7 (12%)
Follow-up
Mean (years) 24.8 26.8 34.0
FIGURE 9.
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TABLE 9. 
Predisposing factors for intracranial aneurysms. ADPKD=autosomal 
dominant polycystic kidney disease.
Predisposing factor No. of patients Mean age (yrs)
Aortic coarctation 3 15
ADPKD 1 6
Congenital heart disease 1 16





In 89 (78%) of a total of 114 patients, the 
aneurysm presented as SAH (Table 10). The 
diagnosis of SAH was based on lumbar punc-
ture, CT, operative findings, or clinical as-
sessment. The most common circumstances 
during which the aneurysm ruptured are 
presented in Table 11. Fisher classification 
was available for nine patients (Table 12). 
TABLE 10. 
Diagnosis of  subarachnoid hemorrhage on 
admission (n=89). CSF= cerebrospinal fluid, 
CT=computed tomography.
No.of patients %
Bloody CSF 77 87
At operation 2 2
Clinically• 1 1
Positive CT 9 10
89 100
The majority of patients were in a good neuro-
logical state on admission (Table 13). Up untill 
the 1980s, SAH-patients were typically first 
treated with bed rest and operations were 
performed 2-3 weeks later. Later Hunt & Hess 
scores were better than the initial ones; how-
ever, two patients died due to rebleedings dur-
ing this waiting period. There was no correla-
tion with the initial Hunt & Hess grades and the 
time period of treatment. Early radiographic 
vasospasm was diagnosed in 20 (23%) of 89 
SAH-patients. In almost 30% of the cases, there 
was a delay in the diagnosis of SAH (Table 14). 
•Patient also had aortic stenosis
•Clear history of sudden severe headache, and 
a bleeding was not ruled out.
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TABLE 11. 
Most common circumstances (≥ three patients) 
during which an aneurysm ruptured.
No. of 
patients








Fisher classification of patients with 
subarachnoid hemorrhage and initial 






< 1 mm 1
> 1 mm 0
IVH/ICH 8
TABLE 13. 
Initial and preoperative Hunt & Hess classification.






0 12 11 6 11
1 6 5 40 51
2 57 49 19 23
3 20 18 8 10
4 10 9 2 3
5 9 8 2 3
114 100 77 100
•Positive lumbar puncture
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TABLE 14. 
Reasons for delay in diagnosis of aneurysm.
Reason for delay No. of 
patients
%
No delay 80 70
Patients or relatives 10 9
Primary physician 5 4
Local/Central hospital delay 4 3
University hospital 3 3
Other 12 10
114 100
5.3.2. Location, size, number, and 
etiology 
The 114 patients were initially diagnosed with 
121 aneurysms, with 13 patients having mul-
tiple aneurysms initially; 11 patients (10%) 
had two, one patient (1%) had three, and 
another patient (1%) had four aneurysms. In 
the 34-year follow-up, the total number of an-
eurysms was 157, including 11 recurrent and 
25 de novo aneurysms. The most common 
location for the initial aneurysm was the ICA 
bifurcation, whereas for de novo aneurysms 
ICA bifurcation, PCoA, and MCA bifurcation 
were equally common (Table 15, Figure 10). 
The aneurysms were of medium size (Table 
16), and no statistically significant difference 
existed between size and rupture status of the 
aneurysms. The majority of aneurysms were 
saccular (Table 17). No infectious aneurysms 
were present in our series.
FIGURE 10.
Location of initial aneurysms with proportions 
in pediatric aneurysm patients in this series.
ACA = anterior cocerebral artery, BA = basilar 
artery, ICA = internal cerebral artery, MCA = 









Location of aneurysms. A1 = first segment of anterior cerebral artery, ACA=anterior cerebral artery 
AChA=anterior choroidal artery, ACoA=anterior communicating artery, MCA=middle cerebral 
artery, ICA=internal carotid artery, PCA=posterior cerebral artery, PCoA=posterior communicating 
artery, PICA=posterior inferior cerebral artery, SCA=superior cerebellar artery.
Location Initial Aneurysms (%) New aneurysms (%)
ICA 56 (43%) 15 (42%)
Bifurcation 36 (28%) 7 (19%)
Cavernous 9 (7%) -
PCoA 5 (4%) 7 (19%)
Ophthalmic 3 (2%) 1 (3%)
AChA 3 (2%) -
ACA 43 (33%) 8 (22%)
ACoA 32 (25%) 5 (14%)
Pericallosal 7 (5%) -
A1 3 (2%) 3 (8%)
Anterior others 1 (1%) -
MCA 17 (13%) 10 (28%)
Main trunk 6 (5%) 1 (3%)
Bifurcation 6 (5%) 7 (19%)
Peripheral 5 (4%) -
Basilar 7 (5%) 2 (6%)
PCA 4 (3%) -
PCoA 2 (2%) -
Posterior others 2 (2%) -
SCA - 2 (6%)
PICA 2 (2%) 1 (3%)
Vertebral 1 (1%) -
121 36















Ruptured (n=89) 9 9 2-50
Unruptured (n=32) 21 5 2-55
New aneurysm
Ruptured (n=7) 11 11 6-15











Early radiographic vasospasm was diagnosed 
in 20 (23%) of 88 SAH patients (general five, 
local 15). One SAH-patient died before an 
angiography was performed. Early vasospasm 
was diagnosed from the first conventional 
diagnostic angiography, most often performed 
soon after admission, a median of nine days 
after the SAH. Postoperatively, altogether 
three patients had symptomatic angiographic 
vasospasm. Two patients had focal 
deficits, and one patient had deterioration 
of consciousness. In addition to these, 
asymptomatic radiographic vasospasm was 
diagnosed in 29 patients (36%) after surgery. 
Postoperative angiography was performed a 
median of 15 days after the SAH. 
No correlation existed between early and post-
operative vasospasm. The existence of early 
or postoperative vasospasm also showed no 
correlation with gender or age of the patient, 
location or size of the aneurysm, or initial 
Hunt & Hess grade. Patients with early vaso-
spasm had poorer outcome at both discharge 
and long-term follow-up. Postoperative vaso-
spasm correlated with outcome only at long-
term follow-up. There was no mortality relat-
ed to vasospasm in this patient series.
Treatment for postoperative vasospasm was 
classical triple-H, i.e. hypervolemia, hyper-
tension, and hemodilution. Nimodipine was 
used since 1989.338 No angioplasties were per-
formed on these patients.
Early hydrocephalus was diagnosed in four of 
the 89 SAH patients. Two of these patients had 
an EVD before operation and one had a ven-
triculostomy via the lamina terminalis during 
the aneurysm operation.169 The fourth patient 
was managed by observation. Three patients 
had a shunt operation, but in one of them the 
shunt was removed due to infection. Of these 
89 SAH-patients, two (2%) had permanent 
shunts, both with a posterior circulation an-
eurysm. Only one patient with an unruptured 
aneurysm had a shunt; this patient had a gi-
ant fusiform basilar aneurysm causing hydro-
cephalus. None of the patients with traumatic 
aneurysms developed symptomatic or radio-
graphic hydrocephalus.
•All of the de novo aneurysms 
were saccular in shape.

5.4. Treatment of pediatric 
aneurysms
5.4.1. Ruptured aneurysms
The majority of the ruptured aneurysms were 
actively treated, whereas in the early years 
of our series, unruptured aneurysms were 
treated conservatively (Table 18). Reasons 
for conservative treatment were poor neu-
rological status on admission, technical diffi-
culties during the 1950s and 1960s and fam-
ily reluctance for operative treatment. The 
proportion of conservative treatment was 
highest during the earlier years in our series 
(p<0.05). 
Surgical techniques included a variety of 
methods (Table 19), with clipping of the 
aneurysm being the most common. Intra-
operative aneurysm rupture occurred in 17 
operations. Re-operation was required in 10 
patients, mainly due to incomplete occlusion 
of the aneurysm in the postoperative angiog-
raphy. For one patient, a decompressive cra-
niectomy was performed for massive brain 




Detailed information on surgical treatment. EC-
IC=extracranial-intracranial, ELANA= Excimer 
laser-assisted nonocclusive anastomosis.
No. of  Aneurysms (%)
Ruptured aneurysms Unruptured aneurysms
Surgery 70 (85%) 10 (24%)
Endovascular 2 (2%) -
Conservative 10 (12%) 31 (76%)
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The surgical approach for anterior circula-
tion aneurysms has traditionally been pteri-
onal; however, in recent years, it has been a 
modification of this approach, mainly lateral 
supraorbital. 83
Endovascular treatment
The treatment of aneurysms was purely endo-
vascular for only two patients. A 15-year-old 
girl had a large ruptured basilar tip aneurysm 
and was referred to another neurosurgical in-
stitute for GDC-embolization because at that 
time this particular method was not available 
at our department. 
FIGURE 11. 
A 3-year-old boy had a gunshot wound in the right ear and carotid canal (A-C). Three years later, the 
patient had massive epitaxes.  Angiography showed a traumatic aneurysm in the right cavernous in-
ternal carotid artery (D). The aneurysm was successfully coiled (E). Control angiography five years 
after coiling and eight years after the initial trauma showed an occluded aneurysm (F).
A 3-year-old boy with a gunshot wound to 
the head and zygoma presented with massive 
epitaxes three years after the initial trauma, 
which had been treated conservatively (Figure 
11). A traumatic ICA aneurysm was diagnosed 
and successfully coiled. One de novo aneu-
rysm diagnosed 37 years later was coiled at 
another hospital. Two more patients are wait-
ing for a stent-assisted coiling of their newly 





Of the 130 aneurysms in publication I, 37 were 
treated conservatively mainly because of poor 
neurologic condition on admission, limited 
surgical techniques, or parental refusal of an 
operation. Seven of the 18 patients who sur-
vived the initial bleeding had rebleedings, 
with five (28%) of them being lethal. The first 
rebleeding was not lethal in any of these pa-
tients. There was no correlation between the 
time of treatment (decade), gender, or age of 
the patient, location or size of the aneurysm, 
or initial Hunt & Hess grade and the number 
of rebleedings. Moreover, no correlation ex-
isted between outcome at discharge and re-
bleedings. Two of the primarily conservatively 
treated patients were later surgically treated.
Eight (44%) of the 18 conservatively treated 
SAH patients had a good clinical outcome, 
i.e. GOS 4-5, at the end of 2010. A favorable 
long-term outcome among the conservatively 
treated patients did not correlate with  age or 
gender of the patient, location or size of the 
aneurysm. 
5.4.2. Unruptured aneurysms
During the earlier years unruptured aneu-
rysms were not systematically surgically treat-
ed. Figure 12 presents a 13-year-old girl who 
had been diagnosed with epilepsy two years 
earlier, with no initial imaging of the brain. 
Seizures became more frequent and head 
magnetic resonance imaging (MRI) and MRA 
were performed, showing a left giant middle 
cerebral artery (MCA) aneurysm, which was 
successfully treated. At the 5-year follow-up, 
the patient was asymptomatic and the anti-
epileptic medication was withdrawn. No new 
aneurysms were diagnosed in the follow-up 
MRA.
One 17-year old girl had a giant unruptured 
left vertebral artery aneurysm that presented 
with cranial nerve deficits and ataxia. The an-
eurysm was treated with a Crutchfield® instru-
ment. The clamp was closed on 1st postopera-
tive day. A few hours after closing of the clamp, 
the patient developed right hemiplegia and 
swallowing difficulties and became stuporous. 
The clamp was opened and the symptoms re-
solved. However, after opening of the clamp, 
the patient had a sudden severe headache 
and lost consciousness. SAH was diagnosed by 
lumbar puncture. The patient had respiratory 
arrest and died. Autopsy verified that the gi-
ant left vertebral aneurysm had ruptured and 
resulted in massive SAH and hydrocephalus.
5.4.3. Traumatic aneurysms
Ten patients had traumatic aneurysms. 
Four of these patients had primary trauma 
surgery, craniotomy for subdural and epidural 
hematomas, EVD for intracranial pressure (ICP) 
control, and occlusion of a CSF-fistula. All of 
the traumatic aneurysms were diagnosed from 
the primary angiographies. Three patients died 
due to primary head trauma. Two patients had 
SAH 14 days and 20 days after the trauma, and 
in both cases the ruptured aneurysms were 
treated microsurgically. A patient case with 
a gunshot wound and a traumatic cavernous 
ICA aneurysm is presented in Figure 11.
5.4.4. Extent of aneurysm occlusion
Postoperatively, conventional angiography 
(n=72), or CT-angiography (n=2) was per-
formed to verify the exclusion quality in oper-
atively treated patients. Postoperative studies 
were unavailable for 10 patients. These 10 pa-
tients consisted of three patients with extra-
cranial proximal artery occlusion in the neck, 
three patients with wrapped aneurysms, two 
patients whose surgery was limited to the ex-
ploratory stage, and two patients with clipped 
aneurysms. 
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FIGURE 12. 
Giant left middle cerebral artery (MCA) bifurcation aneurysm in a 13-year-old girl presenting with 
epileptic seizures; computed tomography angiograhy (CTA), 3-D CTA and digital subtraction angi-
ography (A-C). Aneurysm dome exposed (D).  Temporary clips and decompressing the aneurysm 





Postoperatively, 68% of the aneurysms 
were completely occluded, 10% were par-
tially occluded, and 11% were open. Half 
of the patients with completely open aneu-
rysms had a fatal re-bleeding, at a median 
of 64 days (range 4 days-19 yrs). There was 
a statistically significant correlation between 
aneurysm exclusion quality and time of 
treatment (decade); in later years, the com-
pleteness of aneurysm closure was higher.
 
One conservatively treated patient had a con-
trol angiography four months after SAH of a 
left distal MCA aneurysm. The aneurysm had 
totally thrombosed in the control angiography.
5.5. Short-term outcome 
The mean duration of hospital stay was 15 days 
(median 12 days, range 0-46 days). Nine pa-
tients died during hospitalization, with causes 
of death being severe SAH (n=4), rebleeding 
before treatment (n=2), treatment complica-
tion (i.e. main vessel occlusion) (n=2), and 
bleeding after treatment (n=1). During the first 
year after SAH two conservatively treated pa-
tients died due to rebleedings, at one month 
and at ten months after primary bleedings. 
Two patients died due to rebleedings after op-
erative treatment two and three months af-
ter initial bleeding; one of these patients had 
a totally open wrapped ACoA aneurysm and 
the other a by partially closed (by clipping) ICA 
bifurcation aneurysm. There were no deaths 
associated with vasospasm. All deaths during 
the first year after admission to the Depart-
ment of Neurosurgery were aneurysm- or 
treatment-related. Two of these patients had 
unruptured aneurysms. The overall mortality 
during the first year after SAH was 13%. Of all 
the deaths during the follow-up period, 41% 
occurred during the first year after diagnosis.
At discharge, 73 (64%) patients had a favorable 
outcome (GOS>3), 24 (21%) were dependent, 
and 3 (3%) were in vegetative state. Fourteen 
patients (12%) had died. The outcome of pa-
tients at discharge correlated with patients’ 
age, i.e. younger patients had poorer out-
come. Unfavorable outcome correlated also 
with the initial Hunt & Hess grade and early 
vasospasm. However, the outcome of patients 
at discharge did not correlate with year of 
treatment, gender of patient, location, size, or 
rupture status of aneurysm, treatment meth-
od, or completeness of aneurysm closure. 
5.6. Long-term outcome 
The majority (n=49) of the surgically treated 
patients had a 2-month clinical follow-up at our 
out patient department, with a mean follow-
up time of 66 days (range 14-118 days). A new 
follow-up was organized using a written ques-
tionnaire, which was sent to all  74 patients 
who were alive according to the national pop-
ulation registry; 64 (86%) patients responded. 
Two patients were lost to follow-up due to 
their moving abroad. One patient declined 
to participate and seven did not reply to the 
letters. Eventually, the total coverage was 104 
patients (91%), with a mean follow-up time of 
24.8 years (median 29.6 yrs, range 0-55.8 yrs). 
At the last follow-up, 71 (62%) of the patients 
had recovered well (GOS>3), 3 (3%) were de-
pendent, and 40 (35%) had died. Cause of late 
disability was SAH or treatment  related in 77 %.
The most common neurological deficits were 
memory deficit in 21  patients (32%) and cra-
nial nerve deficit in 12 patients (18%). Four-
ty-three patients (67%) reported having no 
neurological deficits. Neurological deficits 
were associated with partially occluded and 
totally open aneurysms. A total of 94% of 
patients not having any neurological deficits 
had a closed aneurysm, compared with 70% 
of patients reporting a neurological deficit.
Long-term outcome correlated with aneurysm 
location, with anterior circulation aneurysms 
being associated with more favorable out-
comes. The good neurologic condition of the 
patient on admission, i.e. initial Hunt & Hess 
grade, correlated with favorable outcome. 
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Both early and postoperative vasospasms 
were associated with a poorer long-term 
outcome. A favorable outcome did not cor-
relate more strongly with surgical or endo-
vascular treatment than with conservative 
treatment. However, there was a statistically 
significant correlation of long-term outcome 
with completeness of aneurysm closure; pa-
tients with totally occluded aneurysms had 
better long-term outcome. The size of the an-
eurysm and the age or gender of the patient 
were  not correlated with long-term outcome. 
At the end of 2010, the mean age of patients 
who had survived (n=74) was 49 years (range 
11-73 yrs). Seventeen patients (27%) had 
medication for hypertension and 12 patients 
(19%) for epilepsy (Table 20). The majority 
(n=41/64, 64 %) of the patients were former or 
current smokers. At the time of the last follow-
up, 27 patients (42%) were current smokers, 
TABLE 20. 
Detailed information on the general health 
condition of patients at the end of 2010.








Respiratory disease 3 (5%)
Rheumatic disease 2 (3%)




‡Breast cancer, colon cancer, uterine tumor, benign 
soft tissue tumor, benign breast tumor
•von Willebrandt disease
with 29.7 mean years of smoking (range 5-51 
yrs). There were 14 ex-smokers (22%) , with 
16.2 mean years of smoking (range 2-40 yrs). 
The majority (n=58, 91%) of the patients lived 
at home independently without assistance, 
and none of the patients were permanently 
hospitalized (Table 21). Most of the patients 
considered that the aneurysm and its pos-
sible treatment had no effect on their suc-
cess at school or career selection. At the end 
of follow-up majority of the patients were 
working or studying, and 8% had retired 
due to aneurysm-related reasons (Table 22). 
TABLE 21. 
Living arrangements of patients at the last 
follow-up.
TABLE 22. 
Working ability of patients at the end of 2010.











Due to age 5 (8%)
Due to aneurysm 5 (8%)
Due to other illnessess 6 (9%)
Modified work/studies 8 (12%)
66 
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5.7. Long-term mortality and 
excess mortality 
5.7.1. Long-term mortality
Ruptured aneurysms and 
aneurysm-related deaths
Four patients died due to rebleeding during con-
servative treatment, two of whom were first-
year survivors, dying at one and a half years and 
five years after the initial bleedings, respectively. 
Two postoperatively totally open aneurysms had 
lethal rebleedings at three years (MCA aneurysm 
with clipping) and 20 years (MCA aneurysm and 
explorative craniotomy) after initial bleedings. 
One patient with a totally occluded aneurysm 
died due to massive SAH 11 years later. This 
bleeding was due to recurrent aneurysm verified 
at  autopsy. Three patients died due to bleed-
ings from de novo aneurysms at 11, 30, and 33 
years after initial bleedings. All of these patients 
had fully recovered from the initial bleedings.
Unruptured aneurysms 
Only one death was observed in patients with 
unruptured aneurysms after surviving the first 
year after diagnosis. A 17-year-old patient 
had multiple giant fusiform aneurysms. At the 
time of diagnosis, all of the aneurysms were 
unruptured. One of the aneurysms was giant 
thrombosed basilar artery aneurysm, which 
had caused cerebellar and pontine infarctions 
on presentation, and four months later bled. 
The patient recovered reasonably well from the 
infarcts and SAH (GOS 4). An ELANA by-pass 
operation was performed due to right-sided giant 
ICA aneurysm without immediate complications. 
The patient was found dead at home three months 
later. Autopsy revealed high blood alcohol level, 
but no clear evidence of aneurysm-related death.
Ruptured aneurysms and 
aneurysm-unrelated deaths
In the long-term follow-up, one cardiovascular 
death was observed at 37 years after the treat-
ment of a ruptured aneurysm. There were two 
cancer-related deaths, one leukemia and one 
prostate cancer, at 29 years and 40 years af-
ter SAH, respectively. One patient died due to 
pancreatitis and septicemia 19 years after SAH.
For three patients, the actual cause of death was 
uncertain/unconfirmed. One patient had moved 
abroad later and died, but no death certificate 
or autopsy report was available. Another patient 
was found dead at home and no autopsy was 
performed. This death was classified as cardio-
vascular on the death certificate; however, an 
aneurysm-related death can not be excluded. 
The third patient died due to massive intrace-
rebral hematoma and intraventricular bleed-
ing, but no angiography or autopsy was per-
formed to identify the etiology of the bleeding. 
This patient had a ruptured aneurysm that was 
surgically totally occluded 40 years earlier. The 
causes of deaths of these three patients were 
classified as unknown and aneurysm-unrelated.
5.7.2. Long-term excess mortality
Long-term excess mortality was estimated in the 
one-year survival pediatric aneurysm patients 
compared with the matched Finnish popula-
tion. The overall cumulative RSRs in one-year 
survivors (n=88) after diagnosis of an intracra-
nial aneurysm were 0.90 (95% CI 0.80-0.95) and 
0.81 (95% CI 0.67-0.91) at 20 and 40 years after 
the diagnosis, respectively (Table 23 and Figure 
13A). Patients with a ruptured aneurysm (n=77) 
had significant excess mortality, in contrast to pa-
tients with unruptured aneurysms (n=11) (Table 
23 , Figure 13B). Males (n=53) faired worse, with 
excess mortality of 15% and 27% at 20 and 40 
years, respectively,  compared with the cor-
responding figures for females (n=35) of 2% 
and 6% (Table 23, Figure 13C). There was ex-
cess mortality in patients with single (n=77) 
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TABLE 23. 
Cumulative survival ratios and corresponding 95% confidence intervals, stratified by age, gender, 
number of aneurysms, rupture status of the index aneurysm, treatment method, and aneurysm 
status after treatment. N/A = not available.
Cumulative relative survival ratios (95% CI)
at 5 years at 10 years at 20 years at 40 years
0.97 (0.90-0.99) 0.97 (0.90-1.00) 0.90 (0.80-0.95) 0.81 (0.67-0.91)
Age (years)
0-14 1.00 (N/A) 1.01 (N/A) 0.92 (0.73-0.99) 0.79 (0.55-0.93)
15-18 0.95(0.84-0.99) 0.95 (0.84-0.99) 0.89 (0.75-0.96) 0.82 (0.62-0.94)
Gender
Boy 0.97 (0.86-1.00) 0.97 (0.87-1.00) 0.85 (0.71-0.93) 0.73 (0.53-0.88)
Girl 0.97 (0.81-1.00) 0.97 (0.82-1.00) 0.98 (0.82-0.95 0.94 (0.72-1.01)
No. of  aneurysms
Single 0.98 (0.90-1.00) 0.98 (0.91-1.00) 0.90 (0.80-0.96) 0.83 (0.68-0.94)
Multiple 0.91 (0.51-1.0) 0.92 (0.51-1.00) 0.84 (0.46-0.98) 0.66 (0.26-0.93)
Rupture status of aneurysm
Ruptured 0.98 (0.90-1.00) 0.98 (0.91-1.00) 0.90 (0.80-0.96 0.80 (0.65-0.91)




0.99 (0.90-1.00) 0.99 (0.91-1.00) 0.91 (0.79-0.97) 0.81 (0.63-0.93)
Conservative 0.91 (0.67-0.98) 0.91 (0.67-0.98) 0.87 (0.61-0.99) 0.80 (0.51-0.97)
Aneurysm status after treatment
Totally 
occluded
0.98 (0.87-1.00) 0.99 (0.88-1.00) 0.94 (0.81-0.99) 0.87 (0.67-0.98)
Partially 
occluded
1.00 (N/A) 1.01 (N/A) 1.02 (N/A) 0.83 (0.14-1.01)
Open 0.93 (0.73-0.98) 0.93 (0.73-0.99) 0.81 (0.58-0.93) 0.73 (0.47-0.90)
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14 y or younger (n=34)
15 y or older (n=54)






















































Time after diagnosis (years)
FIGURE 13. 
Excess mortality of one-year survival of pediatric aneurysm patients compared with the matched 
Finnish population. Overall cumulative relative survival ratios (RSRs) in one-year survivors (n=88) 
after diagnosis of an intracranial aneurysm (A). Cumulative RSR of 77 patients with ruptured aneu-
rysms and 11 patients with unruptured aneurysms (B), 53 males and 35 females (C), 66 patients with 
actively treated aneurysms and 22 patients with conservatively treated aneurysms (D), 34 patients 
were aged 14 years or less and 54 patients 15 years or more at diagnosis (E), and 51 patients with 
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and multiple (n=11) aneurysms. The type of 
treatment, i.e. active (n=66) versus conserva-
tive (n=22), did not affect the long-term ex-
cess mortality, in contrast to the aneurysm 
occlusion status, which was a significant factor 
(Table 23, Figure 13D and F). Younger patients 
(14 years or younger) tended to have greater 
excess mortality than patients 15 years or older 
at the time of diagnosis (Table 23, Figure 13E). 
No difference existed between saccular (n=81) 
and fusiform (n=7) aneurysms in survival; how-
ever, the low number of fusiform aneurysms 
should be noted. There were no aneurysm-re-
lated deaths among patients with unruptured 
aneurysms in the long-term follow-up after sur-
viving the  first year after diagnosis. Cumulative 
survival ratios and corresponding 95% confi-
dence intervals stratified by age, gender, num-
ber of aneurysms, rupture status of the index 
aneurysm, treatment method, aneurysm sta-
tus after treatment are presented in Table 23. 
5.8. Long-term 
angiographic follow-up
5.8.1. Recurrent SAH and 
new aneurysms
Of the one-year-SAH-survivors (n=77), angio-
graphic follow-up (CTA n=33, MRA n=13 and/or 
DSA n=13) was available in 56 patients (73%) 
and/or neuropathological autopsy in three pa-
tients (4%) (total, 59 patients (77%)). The median 
follow-up was 34.0 years (mean 32.5 yrs, range 
4-56 yrs). During this time a total of 23 patients 
(44%) with a previous SAH (n=52) had de novo 
and/or recurrent aneurysms; there were 25 de 
novo-aneurysms and 10 recurrent aneurysms, 
and eight patients (33%) had multiple new aneu-
rysms. The median times for diagnosis of symp-
tomatic and asymptomatic aneurysms were 19.9 
FIGURE 14.
 A 16-year-old girl with seizures was diagnosed with an unruptured 
internal cerebral artery bifurcation aneurysm (A) that was clipped. 
Six years later seizures severed with angiography revealing a large 
recurrent aneurysm (B and C). The recurrent aneurysm was succes-
fully clipped (D). 
years (mean 19.9 yrs, 
range 11-33 yrs) and 
36.0 years (mean 37 yrs, 
range 26-47 yrs), respec-
tively, in patients with 
previous SAH. Thus, 
patients with symptom-
atic new aneurysms 
were younger (median 
33 yrs, range 22-50 yrs) 
than patients with as-
ymptomatic aneurysms 
(median 50 yrs, range 
40-62 yrs). Eight (27%) 
of all de novo/recurrent 
aneurysms presented 
with SAH, with an early 
mortality of 57%. There 
were no de novo aneu-
rysms in patients with 
previous unruptured an-
eurysms; however, one 
patient had a symptom-





ure 14). Asymptomatic growth of an untreated 
aneurysm was diagnosed in three patients (5%). 
Spontaneous thrombosis was diagnosed in three 
patients (5%). Thirty-five patients (59%) were for-
mer (n=11, 19%) or current (n=24, 41%) smokers, 
and 26 (44%) had a diagnosis of hypertension. Six 
of the eight patients with multiple aneurysms 
were current (n=5) or former (n=1) smokers.
Of the de novo aneurysms, 24% were located on 
the ipsilateral side to the initial aneurysm. Symp-
tomatic aneurysms were larger than asymptom-
atic ones, with median sizes of 15.0 mm (mean 
14.8 mm, range 6-28 mm) and 3.0 mm (mean 
6.2 mm, range 1-14 mm), respectively (p>0.05). 
Of the original 102 patients, 34 had died by the 
end of 2010. Of them, four had died due to a 
SAH from a de novo aneurysm. Five patients 
had a new aneurysm located in posterior circula-
tion, but only two of them had had a four-ves-
sel angiography initially. One patient had verified 
aneurysmal SAH, intraventricular hemorrhage 
(IVH), and large midline frontal hematoma 
around a previously totally clipped ACA aneu-
rysm. No angiography was performed and the 
autopsy report did not specify whether the new 
FIGURE 15. 
Kaplan Meier survival analysis on a new SAH.
























ruptured aneurysm was de novo or recurrent.
5.8.2. Annual rates and risk factors
During 1935 person-years of follow-up the an-
nual rate of hemorrhage (n=7) was 0.4% and 
development of de novo or recurrent aneu-
rysm (n=36) was 1.9%. In patients with previ-
ous SAH (1766 person-years of follow-up), the 
corresponding rates were 0.5% and 2%. Sepa-
rate annual rates for de novo (n=25) and recur-
rent (n=11) aneurysms were 1.3% and 0.6%, 
respectively, for all the patients. The only statis-
tically significant risk factor for new aneurysm 
formation was current or previous smoking (OR 
3.39; 95% CI 1.02 to 11.29; p=0.047). For pa-
tients with ruptured aneurysm in the childhood 
the risk was even higher; OR 4.92; 95% CI, 1.32 
to 18.39 (p=0.018). Hypertension, gender, age 
of the patient initially, initial number of aneu-
rysms, initially ruptured aneurysm, family his-
tory for aneurysms, or previous parent artery 
occlusion had no statistically significant effect 
on new angiographic findings. None of the ac-
knowledged risk factors had a statistically sig-
nificant role in occurence of a new SAH; howev-
er, smoking seemed to have an impact, 
although it did not quite reach statis-
tical significance (p=0.077).  Kaplan-
Meier statistical analysis on survival of 
a new SAH is presented in Figure 15.
5.8.3. Treatment of new 
aneurysms
All symptomatic new aneurysms were 
treated actively at three of the five 
University Hospitals in Finland during 
1989-2011, except for four patients dy-
ing soon after SAH. All of the patients 
with a new asymptomatic aneurysm 
have been referred to a consultation 
with a local neurosurgeon (Figure 16). 
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FIGURE 16. 
A 59-year-old female had three new left-sided asymptomatic aneurysms (recurrent poste-
rior communicating artery (PCoA) aneurysm 6 mm, de novo internal cerebral artery (ICA)-
ophthalmic aneurysm 3 mm, and de novo superior cerebellar artery aneurysm 3 mm) 41 
years after successful clipping of a ruptured left PCoA aneurysm. Two of the aneurysms 
(PCoA and ICA-ophthalmic) were treated successfully with stent-assisted coiling (A and 
B), with antiplatelet medications started afterwards. Two months after coiling, the pa-
tient sustained a large spontaneous intracranial hematoma (C and D) which was operat-











This study presents a single-center consecutive 
series of pediatric patients with intracerebral 
aneurysms together with a literature review. 
To date, this is the largest reported series on 
these rare patients. Descriptive data for these 
patients are presented. The clinical long-term 
follow-up data with later co-morbidities, neu-
rological outcome, and educational status and 
employment are presented over a mean follow-
up time of 25 years. The long-term risk of these 
patients harboring de novo and recurrent an-
eurysms, possibly leading to SAH, and factors 
affecting this risk are assessed.  Excess mortal-
ity and contributing factors are determined. 
Age and gender
In our study, there was a male predominance 
(61%) for aneurysm formation, consistent 
with the literature review. Among adults, the 
majority of aneurysm patients are females. 
However, a meta-analysis study found that 
the incidence of SAH was significantly higher 
in men than in women in the age group 25–45 
years, while  in the age group 55–85 years, the 
incidence was significantly higher in women.37
Predisposing factors 
The main risk factors for aneurysm formation 
and rupture in the adult population are hyper-
tension, smoking, excessive alcohol abuse, pre-
vious aneurysm rupture, and female gender. In 
our series there were seven patients (6%) with 
a known predisposing factor. Three patients 
had aortic coarctations with hypertension, and 
all were operated on later. One patient had AD-
PKD. One patient had a hypoplastic aortic wall. 
There was one patient with tuberous sclerosis 
complex and multiple giant fusiform aneurysms. 
Intracranial vascular lesions are very rare in tu-
berous sclerosis, and seldom are intracranial 
aneurysms reported in these patients.96,111,271 
Beltramello et al.9 suggested that intracranial 
aneurysm can be added to the nonprimary di-
agnostic features for the clinical diagnosis of 
tuberous sclerosis complex; however, a recent 
paper did not recommend routinely screen-
ing for vascular lesions in these patients.248 
In a recent publication by Sanai et al.,250 the 
proportion of significant comorbid disease 
was as high as 28%, contrary to our series. 
Our series was collected over a long pe-
riod, and in the early years possible under-
lying connective tissue disorders may have 
gone unnoticed. However, when studying 
the medical records and written question-
naire no indication emerged of connective 
tissue disorders in the patients later in life. 
There were altogether 14 patients with a  posi-
tive family history, i.e. a first-degree relative(s) 
had a diagnosis of an intracranial aneurysm. 
According to our results in pediatric patients, 
there is no tendency for increased family history 
of cerebral aneurysms compared with adults.240
Presentation 
Most aneurysms (78%) in this series were rup-
tured. Despite a clear delay in the diagnosis 
of an aneurysm after classical symptoms of 
SAH, the majority of the patients were in good 
condition on admission. Surprisingly, the neu-
rologic condition of patients on admission was 
not significantly better during the modern era, 
as would be expected due to major advances 
in emergency care and neurointensive care. 
Aneurysm characteristics and etiology
Most aneurysms (89%) were located in the 
anterior circulation, especially in the ICA and 
ACoA. This is in good agreement with the 
literature review on pediatric aneurysm pa-
tients, thus differing from location in adults 
(see Figure 1). Also, the patients in our series 
had a lower frequency (12%) of multiple an-
eurysms than adult patients (about 30%). The 
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mean sizes of ruptured aneurysms (9 mm) 
and unruptured aneurysms (21 mm) were 
slightly larger than those reported in the adult 
population in Finland (7 mm).100 The propor-
tion of giant aneurysms was slightly higher 
(12%) than that in the adult population (5%).161 
In our series, there were 10 patients with trau-
matic aneurysms. Seven of these 10 aneurysms 
were located in the distal branches of either 
the ACA or MCA. These patients were younger 
than those with spontaneous aneurysms. In 
three patients, the aneurysms bled later, at a 
mean of 4 weeks. The major causes for high-
energy trauma were motor vehicle accidents 
in the 1950s, 1960s and 1970s. Nowadays, 
angiography is not used as the primary imag-
ing method in trauma cases so asymptomatic 
traumatic aneurysms may remain hidden. Fur-
thermore, children may have a greater ten-
dency for traumatic aneurysms than adults. 
As previously stated by Yazbak et al.,333, the 
formation of a traumatic aneurysm should 
be considered in a patient with a history of 
head injury with new neurological symptoms.
No mycotic aneurysms were present in our 
series. 
Conservative treatment
A large proportion of conservatively treated pa-
tients (44%) with a ruptured aneurysm in child-
hood have a good long-term outcome. This is 
surprising, especially when taking into account 
ongoing smoking among these patients. How-
ever, almost one-third of patients had died 
due to re-bleedings without the proper fol-
low-up imaging recommended today. The inci-
dence of rebleedings was not associated  with 
any specific factor in patients or in aneurysms 
among the conservatively treated patients.
Microsurgical versus 
endovascular treatment
Debate over the two treatment modalities, 
microsurgical and endovascular, is ongoing. A 
recent paper found microsurgery to be more 
efficacious and durable, especially when con-
sidering the long life expectancy of children.250 
Another study promotes endovascular treat-
ment over surgery.2 Sanai et al.249 found that the 
number of de novo aneurysms was considerably 
higher in the endovascularly treated patients, 
thus suspecting that the coiling procedure itself 
harms the previously somewhat fragile vessel 
wall, predisposing to aneurysm formation. In 
our series, the majority of the patients were 
microsurgically treated, even during the last 20 
years, when endovascular treatment has been 
available. This is partly because of our vast ex-
perience in microsurgery. Due to the small num-
ber of endovascularly treated patients in our 
series, no statistical comparison between the 
two treatment methods could be performed. 
Outcome
The fact that classical connective tissue dis-
orders were not diagnosed in our series led 
us to suspect that these patients have some 
systemic vascular disorders that would pre-
dispose them in the future to cardiac diseases 
or other cerebrovascular events. This, how-
ever, was not the case, with the exception of 
de novo aneurysms. The incidence of hyper-
tension, hypercholesterolemia, stroke, etc., 
was no higher than in the age-matched Finn-
ish population. Also there was no increase 
in the incidence of autoimmune disorders. 
In our series, the proportion of current smokers 
was over three-fold that of the general popu-
lation in Finland.279 In addition, there was a 
long history of smoking among these patients. 
The two most significant factors associated 
with a favorable long-term outcome were an-
eurysm location in the anterior circulation and 
complete aneurysm closure. Furthermore, 
good neurologic condition of the patient on 
admission and absence of early and postop-
erative vasospasm correlated with a good 
outcome. In our series, the timing of the first 
angiography was relatively late, i.e. nine days 
after SAH, compared with the modern practice.
 




The treatment method had no correlation 
with the outcome, mainly due to inefficient 
completeness of aneurysm closure during the 
early years. Incomplete aneurysm closure, by 
contrast, was associated with neurological def-
icits. It is noteworthy that although one-third 
of patients in our series had a neurologic defi-
cit they managed well in their lives and most 
of them considered that the aneurysm and its 
treatment had not affected their lives with re-
gard to education, career, or social activities.
 
It is reasonable to assume that children have 
an overall better recovery potential than 
adults for cerebral assaults as well as for many 
other diseases. Comorbidities, such as un-
derlying atherosclerosis, hypertension, and 
diabetes, are virtually non-existent or have 
a very short duration in children. In addition 
to the initial hemorrhage, rebleeding and 
vasospasm are the leading causes of mor-
bidity and mortality in SAH patients. In our 
series, no patients died due to vasospasm, 
and among pediatric patients the incidence 
of delayed cerebral ischemia has been re-
ported to be low,207,216,225 possibly due to ca-
pable leptomeningeal collateral circulation.159
 
In our series, one-third of patients reported 
neurological deficits, with slight hemiparesis 
and cranial nerve deficits being most common. 
However, even though patients might lack ma-
jor motor neurological deficits, they may have 
impaired memory. Memory deficit was the 
most common deficit reported. Patients were 
also able to classify the memory deficit as an-
eurysm–related or unrelated. In an SAH patient 
study with adult patients, Hackett et al. 75 found 
that good-outcome patients may have high-
level deficits in memory and other cognitive 
functions, which became obvious in neuropsy-
chological examination.In our series, no neuro-
psychological tests were carried out. However, 
level of education was determined together 
with employment status and line of work. 
Search for predisposing factors
In this study, only a minority of the children had 
classical predisposing systemic connective dis-
ease. When dealing with a child with an intra-
cranial aneurysm, recognition of an underlying 
systemic connective tissue disorder may be of 
considerable importance, although marked 
phenotypic heterogeneity often complicates 
the diagnosis of these disorders.257 Abdominal 
ultrasound to exclude polycystic kidneys is an 
inexpensive examination with excellent avail-
ability and precision. For every child with an in-
tracranial aneurysm and high blood pressure, 
aortic coarctation and other cardiac disorders 
in addition to secondary etiologies for hyper-
tension should be excluded. Furthermore, as 
pointed out by Schievink et al.,257 the associa-
tion of certain neurovascular anomalies with 
systemic connective tissue disorders and rec-
ognition of their basic molecular defect may 
offer clues to the etiology and pathogenesis 
of these neurovascular diseases in general.
New aneurysms
In our series, almost 40% of the patients de-
veloped new aneurysms over the long fol-
low-up (mean 34 years). The only risk factor 
found was smoking, which among patients 
with previously ruptured aneurysms raised 
the OR to 5. There were no de novo aneu-
rysms among patients with unruptured an-
eurysms. However, the number of patients 
with unruptured aneurysms was small, which 
might have had an impact on this finding. In 
our risk factor study, however, a ruptured 
aneurysm status was not an independent 
risk factor for new aneurysm formation.
 
Previously, annual rates of up to 2.6% for de 
novo aneurysms and 3.5% for recurrent aneu-
rysms among pediatric patients have been re-
ported;117 these are high relative to our study 
(1.3% and 0.6%, respectively). However, the 
patient inclusion criteria differ markedly; in 
the study from Barrow Neurological Institute 
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(BNI)117 also AVM-related aneurysm patients 
and patients with iatrogenic, traumatic, and 
infectious aneurysms were enrolled. Our re-
sults are in concordance with adult aneurysm 
patient studies, where the annual rate for de 
novo aneurysms has varied between 1.8% and 
4%20,36,113 and the rate for annual recurrent an-
eurysm formation after clipping has ranged 
from 0.06% to 0.5%.36,302,323 In our series, 
the annual risk of developing de novo aneu-
rysms was threefold that of deleloping recur-
rent aneurysms,  in concordance with previ-
ous studies in adult aneurysm patients.36,302
 
There has been wide variation in the rate of 
hemorrhage from a de novo or recurrent an-
eurysm, one adult study found no recurrent 
SAHs despite de novo aneurysms,46 whereas 
another36 reported rates that were almost 
fivefold (1.9%) those of our series with pedi-
atric patients. The annual rupture rate in our 
series (0.4%) is consistent with earlier pediat-
ric studies (0.6%).117 It should be noted that 
in Finnish patients the risk of an aneurysm 
rupture is two- to threefold  that in other 
populations. In our study, eight patients (14%) 
experienced a new SAH. The early mortal-
ity from an SAH from a de novo aneurysm 
was high (57%) relative to recent literature.20
Risk factors for new aneurysm and new 
SAH
In our series, the majority of patients were 
current or previous smokers, and half of them 
had hypertension, both known risk factors 
for aneurysm formation, growth, and rup-
ture.116,228,295,320 However, the only statistically 
significant factor for recurrent or de novo 
aneurysm formation was smoking, with an 
OR of almost 5 in patients with previously 
ruptured aneurysms. The impact of a pa-
tient initially harboring multiple aneurysms, 
female gender, or family history of intracra-
nial aneurysms was not significant for later 
developing new aneurysms, contrary to re-
sults in the literature.8,20,36,130 Moreover, the 
rupture status of the previous aneurysm or 
the age of the patient initially were not risk 
factors. There were no de novo aneurysms 
in patients with previous unruptured aneu-
rysms in our series (n=7), even though in 
studies with adult aneurysm patients de novo 
rates of up to 1.06% have been reported.116 
In a study from San Fransisco,250 19% of endo-
vascularly treated patients had de novo aneu-
rysms, in contrast to 6% in the microsurgically 
treated patients. In our series, the only endo-
vascularly treated patient had no new findings 
in a follow-up MRA 16 years after the SAH. 
Ligation of the proximal major vessel and es-
pecially ICA ligations have been reported to be 
associated with symptomatic ACoA de novo 
aneurysms due to hemodynamic changes.42 
In our series, there were two patients with 
previous proximal artery ligation, and one of 
them had a ruptured de novo ACoA aneurysm.
None of the common acknowledged risk factors 
for recurrent SAH had a statistically significant 
role in new SAH in our series; however, smok-
ing seemed to have some  impact, although it 
failed to reach statistical significance (p=0.077). 
The annual rupture rate of a previously un-
ruptured aneurysm in a Finnish patient with 
another ruptured aneurysm is about 1.3%.115
When and whom to follow-up?
In recent years, intracranial aneurysms 
have been speculated to some extent be an 
embodiment of a systemic vascular disease and 
aneurysm formation to be more a continuous 
process than a single unfortunate incident. 
There has been debate over screening for new 
aneurysms among adult SAH patients.255 There 
are risks in preventively treating unruptured 
aneurysms (ISUIA), and even if diagnosed, 
not all aneurysms are treated. Although 
screening is an important preventative 
strategy in high-risk individuals, it has been 
associated with considerable psychosocial 
effects.322 The knowledge of having an 
aneurysm has been observed to have some 
effect on the quality of life. However, even 




in these cases, the possibility to reduce the 
risk factors (e.g. smoking and hypertension) 
for aneurysm growth and rupture is valuable. 
Cigarette smoking after a history of a ruptured 
aneurysm carries an especially high risk for 
the development of a new aneurysm.255
Among pediatric patients, the risk for a new 
aneurysm is high, particularly considering the 
long life expectancy of a child. This should over-
come the psychological burden of screening. Of 
course, eventually, patients decide themselves 
whether they wish to participate in follow-up. 
Among SAH adult patients, debate exists about 
screening for asymptomatic new aneurysms.112 
However, in children, intracerebral aneurysms 
should be regarded as “a potentially chronic 
progressive condition,” as stated by Hetts et 
al.87 Most of the angiographic follow-up stud-
ies among pediatric aneurysm patients rec-
ommend strict surveillance,87,117 tailored de-
pending on the chosen treatment modality.250 
In our series, the earliest symptomatic recur-
rent aneurysm was found at 6 years after the 
initial treatment, and the first de novo –aneu-
rysms at 11 years after SAH, in concordance 
with reported adult series.302,335 In children, 
long-term angiographic follow-up studies are 
scare. However, one pediatric series reported 
recurrent and de novo aneurysms at a very 
short-term interval of 5 months,117 another at 
5 years.87 Among adult series, a short-term an-
giographic follow-up at 3- to 5-year intervals 
was recommended in patients under 50-years 
of age with hypertension.295 Another study 
suggested follow-up imaging for female pa-
tients at 10 years after the initial aneurysm.228 
Our study indicate that all pediatric aneurysm 
patients should have follow-up imaging re-
gardless of the absence of possible risk factors 
such as smoking, hypertension, female gender, 
and previously ruptured aneurysm. In young 
patients, for whom a life-long angiographic 
follow-up is recommended, MRA, as the saf-
est method, is the preferred imaging modality. 
In our study, MRA was the first-line screening 
method to detect new aneurysms in the long-
term angiographic follow-up. CTA was per-
formed on patients with a contraindication for 
MRI, main reason for this being MRI-incom-
patible, old aneurysm clip. DSA as an addition-
al study was carried out when planning endo-
vascular treatment of a de novo or recurrent 
aneurysm or preoperatively in complex cases. 
Our department has considerable experience 
with CTA, and CTA is currently the preferred an-
giographic imaging method in SAH patients.120 
Treatment of de novo and 
recurrent aneurysms
Treatment of previously treated recurrent 
aneurysms is complex. Due to the prior treat-
ment, the procedure-related complication 
rates are higher in reoperations than in the 
initial treatment.89 In recent years, advanced 
endovascular techniques have become more 
frequent in the treatment of previously 
clipped residual and recurrent aneurysms. The 
choice of treatment method in these complex 
and demanding cases should be discussed 
by a multidisciplinary team of skilled neu-
rosurgeons and neurointerventionists.117,249 
Statistical analysis
We performed the excess mortality study by 
focusing on survival. Some previous studies 
have focused on the mortality rate and ex-
pected deaths by using standardized mortal-
ity ratio. Recent population-based studies on 
excess mortality among SAH patients have 
been carried out by two different methods: 
either the Ederer II method45 or the Hakulinen 
method.77 The Hakulinen method is optimal 
under informative censoring when the rela-
tive survival is constant across the ages. Even-
thoug in our series, the range of patients’ age 
was very narrow and the risk for informative 
censoring low, the Hakulinen method77 was 
chosen. For comparison, we also analyzed 
the data using the Ederer II method, and ob-
tained comparable results (data not shown).
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Intracranial aneurysms in children are rare, consti-
tuting 1-2% of all aneurysm patients. In our series of 
114 patients, the majority of the patients were boys. 
Most aneurysms were ruptured. Of the aneurysms, 
89 % were located in the anterior circulation, the ICA 
bifurcation being the most frequent location. The 
mean size of aneurysms was 11 mm. Most patients 
had a good recovery;  factors correlating with a fa-
vourable long-term outcome were good neurologic 
condition of the patient on admission, aneurysm 
location in the anterior circulation, complete aneu-
rysm closure, and absence of vasospasm. In our se-
ries, the connective tissue disorders common to pe-
diatric aneurysm patients were lacking. There was 
no increased family history of aneurysms in these 
patients compared with adult aneurysm patients.
There was a significant long-term excess mortality 
in pediatric patients with aneurysm even decades 
after successful treatment of ruptured aneurysm, 
being most significant in males. However, there 
was no increased long-term excess mortality in pa-
tients with unruptured aneurysms. The causes of 
death were mainly aneurysm-related, i.e. rebleed-
FIGURE 17. 
Primary screening for systemic predisposing conditions in a child 
with an intracranial aneurysm. ADPKD = autosomal dominant poly-
cystic kidney disease.
ings from incompletely 
treated aneurysms, sei-
zures, and de novo and 
recurrent aneurysms. 
There was a high risk for 
de novo and recurrent an-
eurysm formation in our 
series, up to 41%. The cu-
mulative risk of new SAH 
40 years after the initial 
diagnosis was 15%. Cur-
rent and previous smoking 
were independent risk fac-
tors for de novo and recur-
rent aneurysm formation, 
especially in patients with 
a previously ruptured an-
eurysm. Therefore, cessa-
tion of smoking is essential. 
Our results emphasize the importance of angio-
graphically verified complete occlusion of aneu-
rysms, followed by a life-long angiographic fol-
low-up in children with intracranial aneurysms. 
7.1. Recommendations for 
treatment and follow-up
Ruptured and unruptured aneurysms in children 
should be treated by an experienced microvascular 
or endovascular neurosurgeon. Patients with unrup-
tured, asymptomatic aneurysms should have a con-
sultation with a neurosurgeon, and the aneurysm 
should be actively treated; in very selected cases, 
close observation is might be sufficient. Special at-
tention should be paid to the complete closure of 
the aneurysm. Microsurgical treatment of the an-
eurysm is preferred to endovascular treatment. 
A child diagnosed with an intracranial aneu-
rysm should be evaluated for possible co-mor-
bidities predisposing to intracranial aneurysms 
(Figure 17). A life-long angiographic follow-
up at 3- to 5-year intervals, preferably with 
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HUNT & HESS ScalE97
Grade Signs and symptoms after subarachnoid hemorrhage Survival
1 Asymptomatic or minimal headache and slight neck stiffness 70%
2 Moderate to severe headache; neck stiffness, no neurologic deficit 
except cranial nerve palsy
60%
3 Drowsy, minimal neurological deficit 50%
4 Stuporous; moderate to severe hemiparesis, decerebrate rigidity 20%
5 Deep coma, moribund, decerebrate rigidity 10%
Grade Appearance of hemorrhage on computed tomography
1 None evident
2 Less than 1 mm thick
3 More than 1 mm thick
4 Intraventricular or parenhcymal hematoma
FISHER ScalE54
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APPENDIX II
WRITTEN QUESTIONARY
1. Do you have some symptoms or permanent deficiencies, such as paralysis, vision problems, 
or memory problems, after the diagnosis and/or treatment of the aneurysm?
 
2.  If you answered yes, could you please be more specific? You may also describe your defi-
ciencies in your own words. 
Paralysis of a hand and/or leg 
Vision problem   
Visual field deficit  
Double vision   
Hearing problem   
Difficulty in sense of smell   
Facial paralysis    
Swallowing difficulty   
Memory difficulty   
Balance difficulty    
Concentration difficulty   
Speech production and /or comprehension difficulties             
    
                                                                                                                                                                          
                                                                                                                                                                          
                                                                                                                                                                          
                                                                                                                     
3. Do you smoke?                                                  How long have you smoked?______
                Have you previously smoked?    
 How long did you smoke before cessation?______________
4. Have you had imaging of your brain during the follow-up? 
  
 yes  no
   
 
If you answered yes, please specify when and where?__________________________
5. Have you had a diagnosis of a new aneurysm or new cerebral hemorrhage after the initial 
diagnosis? 
If you answered yes, please specify when and where?__________________________
yes  no       
 yes  no
 yes  no
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6. Do you have a close family member (parent, sibling, offspring) who has been screened for an 
intracranial aneurysm? 
 yes  no
7. Do you have a close family member (parent, sibling, offspring) who has been diagnosed with 
an intracranial aneurysm or a cerebral hemorrhage? 
 yes  no
8. Do you have a diagnosis of a long-term illness?
Heart disease    
Coronary disease/infarction   
Hypertension     
Blood disease/Bleeding disorder   
Lung disease     
Kidney disease     
Diabetes     
Immune deficiency    
Cerebrovascular disorder    
Epilepsy      
Tumor (where)     
Other illness (please specify)  
Aortic coarctation     
                                                                                                                                                                            
                                                                                                                                                                         
                                                                                                        
9. Have you been diagnosed with a rare connective tissue disorder?
 
Marfan syndrome     
Osteogenesis imperfecta     
Ehlers-Danlos syndrome     
Pseudoxantoma elasticum     
Polycystic kidney disease     
Neurofibromatosis     
Other  connective tissue disorder (please specify) 
                                                                                                                                                                          
                                                                                                                                                                          
                                                                                                                   
                                                                                                                                                                     
10. Do you have a close family member (parent, sibling, offspring) who has been diagnosed 
with a rare connective tissue disorder? 
      
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
 yes  no
Pediatric Cerebral Artery Aneurysms
A
ppendix II
11. Do You have continous medication?  
If yes, could you please list your medication(s). 
12. How would you describe your current capability? Usual daily activities include dressing and 
dining. You may also describe your capability in your own words.
 I have no symptoms.
  I have no significant disability. I am able to carry out all usual activities without 
 assistance, despite some symptoms (e.g. headache, vertigo). 
 I have slight disability (e.g. slight weakness in the arm, dysphasia). I am able 
 to look after my own affairs without assistance, but am unable to carry out all 
 previous activities. 
 I have moderate disability. I require some help, but am able to walk unassisted. 
 I have moderately severe disability. I am unable to attend to my bodily needs 
 without assistance and am unable to walk unassisted.
 I have severe disability. I require constant nursing care and attention. I am  bedridden.
                                                                                                                                                                            
                                                                                                                                                                       
                                                                                                                                                                      
                                                                                                                                                                      
                                         
13. Do you have impaired functional capacity? If yes, is it due to intracranial aneurysm or to 
something else? 
 My functional capacity is impaired for reasons related to intracranial aneurysm. 
 My functional capacity is impaired for reasons other than intracranial aneurysm. 
 My functional capacity is not impaired.
                                                                                                                                                                            
                                                                                                                                                                          
                                                                                                                                                                          
                                                                                                                                                                                  
                                       
14. What is your education and profession?  Did the aneurysm or its treatment have any im-
pact on your profession or social life?      
                                                    
15. Comments/questions?
   















WRITTEN QUESTIONARY (in Finnish)
1. Onko teille jäänyt aneurysman diagnosoinnin ja mahdollisen leikkauksen jälkeen jotain py-
syviä puutosoireita, kuten halvausoireita, näköongelmia tai muistiongelmia?
 
2.  Jos vastasitte edelliseen kysymykseen kyllä, tarkentaisitteko? Voitte kuvata myös omin 
sanoin puutosoireitanne.
Käden ja/tai jalan halvausoire   
Näön heikentyminen    
Näkökenttäpuutos    
Kaksoiskuvien näkeminen   
Kuulon heikentyminen   
Hajuaistin heikentyminen    
Kasvohermohalvaus   
Nielemisvaikeus    
Muistiongelma   
Tasapainon heikentyminen   
Keskittymiskyvyn heikentyminen   
Puheen tuottamisen ja/tai ymmärtämisen vaikeus     
                                                                                                                                                                          
                                                                                                                                                                          
                                                                                                                                                                          
                                                                                                                     
3. Tupakoitteko?                                    Kuinka kauan olette tupakoinut?_________
    Oletteko aiemmin tupakoinut?         
    Kuinka kauan tupakoitte ennen tupakoinnin lopettamista?______________
4.Onko seuranta-aikana aivojanne kuvattu? 
     
 
Jos vastasitte kyllä, niin kirjoittakaa missä ja milloin?__________________________
5. Onko teillä seuranta-aikana todettu uusia aivovaltimopullistumia tai aivoverenvuotoja? 
Jos vastasitte kyllä, niin kirjoittakaa missä ja milloin?__________________________
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
kyllä ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
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6.Onko lähisukulaisianne (vanhemmat, sisarukset, omat lapset) kuvattu mahdollisten aivovalti-
mopullistumien löytämiseksi? 
7. Onko lähisukulaisillanne (vanhemmat, sisarukset, omat lapset) todettu aivovaltimopullis-
tumia tai aivoverenvuotoja?  
8. Onko teillä todettu jokin pitkäaikaissairaus?
Sydänvika    
Sepelvaltimotauti/infarkti   
Verenpainetauti  
Verenvuoto-/verisairaus   
Keuhkosairaus   
Munuaissairaus   
Sokeritauti    
Immuunikato   
Aivoverenkierron häiriö   
Epilepsia   
Kasvain (missä)   
Muu sairaus (kuvatkaa)   
Aortan ahtauma (koarktaatio) 
                                                                                               
                                                                                                                                                                         
                                                                                                        
9. Onko teillä todettu jokin harvinainen sidekudossairaus?
 
Marfanin oireyhtymä     
Synnynnäinen luustonhaurastumistauti (Osteogenesis imperfecta) 
Ehlers-Danlos oireyhtymä    
Pseudoxantoma elasticum     




                                                                                                                                                                          
                                                                                                                                                                          
                                                                                                                   
                                                                                                                                                                     
10. Onko  lähisukulaisillanne (vanhemmat, sisarukset, omat lapset) todettu jokin kohdassa 9  
mainituista sairauksista?       
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
 kyllä  ei
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11. Onko teillä säännöllistä lääkitystä?   
Jos vastasitte kyllä, voisitteko kirjoittaa listan lääkkeistänne. 
12. Kuinka kuvaisitte tämänhetkistä toimintakykyänne? Päivittäistoiminnoilla tarkoitetaan mm. 
pukeutumista ja ruokailua. Tarvittaessa voitte kuvata toimintakykyänne omin sanoin.
 Olen oireeton.
 Minulla on oireita (esim. päänsärkyä, huimausta), mutta ei vammaa. Oireistani huoli- 
 matta selviydyn päivittäisistä toiminnoistani omatoimisesti ilman apua.
 Olen lievästi vammautunut (esim. lievä käden halvaus, puhevaikeus). Vammastani  
 huolimatta selviydyn päivittäisistä toiminnoistani omatoimisesti ilman apua.
 Olen kohtalaisesti vammautunut. Tarvitsen apua päivittäisissä toiminnoissa, mutta  
 pystyn kävelemään ilman apua. 
 Olen kohtalaisen vakavasti vammautunut. Tarvitsen huomattavasti apua päivittäisissä  
 toiminnoissani. En pysty kävelemään ilman apua.
 Olen vakavasti vammautunut vuodepotilas. Tarvitsen ympärivuorokautista sairaan- 
 hoitoa.
                                                                                                                                                                            
                                                                                                                                                                          
                      
13. Johtuuko mahdollinen alentunut toimintakykynne aivovaltimoaneurysmasta, vaiko muusta 
sairaudesta?
 Toimintakykyni on alentunut aivoaneurysmasta johtuvista syistä.  
 Toimintakykyni on alentunut muista sairauksista johtuen. 
 Toimintakykyni ei ole alentunut.
                                                                                                                                                                            
                                                                                                                                                                       
                                                                                                                                                                       
                                                                                                                                                                                        
14. Mikä on koulutuksenne ja ammattinne? Oliko aneurysmalla tai sen hoidolla vaikutusta am-
matinvalintaanne tai elämäänne muuten?  
                                                    
15. Kommentteja/kysymyksiä?   
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